{"content":"<li class=\"n-box-item date-title\" data-end=\"1554955199\" data-start=\"1554868800\" data-txt=\"Monday, December 23, 2019\">Wednesday, April 10, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3449836\" data-ts=\"1554932258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEDS\" target=\"_blank\">LEDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449836-semiledsplus-5_3-revenues-rise-68\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SemiLEDs +5.3% as revenues rise 68%</a></h4><ul>   <li>Nanocap firm SemiLEDs (NASDAQ:<a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a>) is <font color=\"green\">up 5.3%</font> postmarket after its <a href=\"https://seekingalpha.com/news/3449784-semileds-reports-q2-results\" target=\"_blank\">Q2 results</a>, where revenues jumped 68%.</li>    <li>GAAP net loss narrowed slightly Q/Q to $0.85M, from a first-quarter loss of $0.978M.</li>    <li>Gross margin on a GAAP basis was break-even, vs. Q1's -23%, and operating margin was -56% vs. Q1's -105%.</li>    <li>It's guiding to Q3 revenues of $1.44M-$1.76M.</li>    <li><a href=\"https://seekingalpha.com/pr/17472970-semileds-reports-second-quarter-fiscal-year-2019-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3449836\" data-linked=\"SemiLEDs +5.3% as revenues rise 68%\" data-tweet=\"$LEDS - SemiLEDs +5.3% as revenues rise 68% https://seekingalpha.com/news/3449836-semiledsplus-5_3-revenues-rise-68?source=tweet\" data-url=\"https://seekingalpha.com/news/3449836-semiledsplus-5_3-revenues-rise-68\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449835\" data-ts=\"1554932037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449835-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/VBTX' title='Veritex Holdings, Inc.'>VBTX</a> <font color=\"green\">+9.9%</font>. <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle S.A.'>SUPV</a> <font color=\"green\">+3.6%</font>. <a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a> <font color=\"green\">+1.1%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a> <font color=\"red\">-6.6%</font>. <a href='https://seekingalpha.com/symbol/VNTR' title='Venator Materials PLC'>VNTR</a> <font color=\"red\">-4.4%</font>. <a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color=\"red\">-4.0%</font>. <a href='https://seekingalpha.com/symbol/STRL' title='Sterling Construction Company, Inc.'>STRL</a> <font color=\"red\">-3.6%</font>. <a href='https://seekingalpha.com/symbol/CTRE' title='CareTrust REIT, Inc.'>CTRE</a> <font color=\"red\">-2.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449835\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$VBTX $SUPV $AACG - After Hours Gainers / Losers https://seekingalpha.com/news/3449835-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449835-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449817\" data-ts=\"1554928942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAC\" target=\"_blank\">SEAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449817-seachange-swings-to-loss-to-cap-challenging-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SeaChange swings to loss to cap &#39;challenging&#39; year</a></h4><ul>   <li>SeaChange (NASDAQ:<a href='https://seekingalpha.com/symbol/SEAC' title='SeaChange International, Inc.'>SEAC</a>) is <font color=\"red\">2.1% lower</font> after hours following a Q4 report where revenues slipped and missed and the company swung to a loss.</li>    <li>A GAAP loss from operations of $19.9M was affected by impairment charges of $17M. Non-GAAP loss from operations was $1.2M, vs. a year-ago income of $3.3M.</li>    <li>It was the end of \"an extremely challenging year\" for SeaChange, Chairman Mark Bonney says. \"We significantly underperformed quarter to quarter and for the full year. The underperformance was principally the result of sales pipeline deficiencies, an ineffective go-to-market strategy and a lengthening of the sales cycle.\"</li>    <li>Revenue breakout: Product, $7.8M (down 20.7%); Service, $9.1M (down 30.2%).</li>    <li>The company's stopping quarterly guidance \"to more closely align with industry practices,\" switching instead to annual views.</li>    <li>For fiscal 2020, it's looking to close 20-25 significant deals for multiple product/service offerings, boost annual revenues by low to mid-double digits, to $70M-$80M despite lower service revenues, and maintain GAAP gross margins in the low 60s percentage range. It sees non-GAAP operating income of $0.03-$0.19/share.</li>    <li><a href=\"http://investors.seachange.com\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449810-seachange-eps-line-misses-revenue\" target=\"_blank\">SeaChange EPS in-line, misses on revenue</a> (Apr. 10 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17473072-seachange-international-reports-fourth-quarter-full-year-fiscal-2019-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3449817\" data-linked=\"SeaChange swings to loss to cap &#39;challenging&#39; year\" data-tweet=\"$SEAC - SeaChange swings to loss to cap &#39;challenging&#39; year https://seekingalpha.com/news/3449817-seachange-swings-to-loss-to-cap-challenging-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3449817-seachange-swings-to-loss-to-cap-challenging-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449805\" data-ts=\"1554928135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COST\" target=\"_blank\">COST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449805-costco-reports-7-march-u-s-comp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costco reports 7% March U.S. comp</a></h4><ul> <li>Costco (NASDAQ:<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a>) reports sales increased 7.4% in March to $13.87B.</li><li>Comparable sales were up 6.9% in the U.S., 3.8% in Canada and 1.6% in other international markets.</li><li>E-commerce sales rose 20.6% Y/Y</li>     <li>The company notes that this year\u2019s five-week March retail month had one extra shopping day versus last year, due to the calendar shift of Easter. This positively impacted total and comparable sales by approximately one to one and one-half percent.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17473046-costco-wholesale-corporation-reports-march-sales-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3449805\" data-linked=\"Costco reports 7% March U.S. comp\" data-tweet=\"$COST - Costco reports 7% March U.S. comp https://seekingalpha.com/news/3449805-costco-reports-7-march-u-s-comp?source=tweet\" data-url=\"https://seekingalpha.com/news/3449805-costco-reports-7-march-u-s-comp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449799\" data-ts=\"1554927828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449799-bed-bath-beyondplus-4-after-strong-eps-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond +4% after strong EPS guide</a></h4><ul><li>Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) reports comparable sales fell 1.4% in <a href=\"https://seekingalpha.com/pr/17473037-bed-bath-and-beyond-inc-reports-results-fiscal-2018-fourth-quarter-full-year\" target=\"_blank\">Q4</a> to just miss the consensus estimate for a 1.3% decline.</li><li>Strong sales growth was recorded in the company's customer-facing digital channels, while sales from stores declined in the mid-single-digit percentage range.</li><li>CEO update: \"In fiscal 2019, we are modeling our operating profit, even including the investments in initiatives, to stabilize, and earnings per share to grow slightly, and for both to accelerate thereafter, as the impact from many of our key initiatives grows and we take advantage of the significant operating leverage of our business.\"</li><li>FY19 EPS guidance is set at $2.11 to $2.20 vs. $1.82 consensus.</li><li>BBBY <font color=\"green\">+3.85%</font> AH.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449794-bed-bath-and-beyond-beats-0_10-misses-revenue\" target=\"_blank\">Bed Bath &amp; Beyond beats by $0.10, misses on revenue</a> (April 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3449799\" data-linked=\"Bed Bath &amp; Beyond +4% after strong EPS guide\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond +4% after strong EPS guide https://seekingalpha.com/news/3449799-bed-bath-beyondplus-4-after-strong-eps-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3449799-bed-bath-beyondplus-4-after-strong-eps-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449798\" data-ts=\"1554927611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDSI\" target=\"_blank\">BDSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449798-biodelivery-sciences-nabs-u-s-rights-to-oic-med-shares-down-5-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioDelivery Sciences nabs U.S. rights to OIC med; shares down 5% on equity offering</a></h4><ul><li>BioDelivery Sciences International (NASDAQ:<a href='https://seekingalpha.com/symbol/BDSI' title='BioDelivery Sciences International, Inc.'>BDSI</a>) <a href=\"https://seekingalpha.com/pr/17473007-biodelivery-sciences-international-inc-announces-proposed-underwritten-public-offering-common\" target=\"_blank\">initiates </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li><li>Net proceeds will, undoubtedly, be used to fund the launch of opioid-induced constipation med Symproic (naldemedine). The company just acquired exclusive rights in the U.S. and Puerto Rico from Shionogi (<a href='https://seekingalpha.com/symbol/SGIOY' title='Shionogi & Co., Ltd.'>OTCPK:SGIOY</a>).</li><li>Under the terms of the license, BDSI will pay Shionogi $20M upfront, an additional $10M in six months and tiered royalties on net sales.</li><li>BDSI now forecasts long-term product sales of $325M - 400M per annum. It also expects to be operating cash flow-positive by year-end.</li><li>Shares are down <font color=\"red\">5%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449798\" data-linked=\"BioDelivery Sciences nabs U.S. rights to OIC med; shares down 5% on equity offering\" data-tweet=\"$BDSI $SGIOY $SGIOF - BioDelivery Sciences nabs U.S. rights to OIC med; shares down 5% on equity offering https://seekingalpha.com/news/3449798-biodelivery-sciences-nabs-u-s-rights-to-oic-med-shares-down-5-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3449798-biodelivery-sciences-nabs-u-s-rights-to-oic-med-shares-down-5-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449786\" data-ts=\"1554926899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRE\" target=\"_blank\">CTRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449786-caretrust-launches-stock-offering-shares-down-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CareTrust launches stock offering; shares down 5% after hours</a></h4><ul><li>CareTrust REIT (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRE' title='CareTrust REIT, Inc.'>CTRE</a>) <a href=\"https://seekingalpha.com/pr/17472981-caretrust-reit-inc-announces-launch-public-offering-common-stock\" target=\"_blank\">commences </a>a public offering of 5.25M common shares. Underwriters over-allotment is an additional 787.5K shares. Price and terms have yet to be announced.</li><li>Shares are down <font color=\"red\">5%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449786\" data-linked=\"CareTrust launches stock offering; shares down 5% after hours\" data-tweet=\"$CTRE - CareTrust launches stock offering; shares down 5% after hours https://seekingalpha.com/news/3449786-caretrust-launches-stock-offering-shares-down-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3449786-caretrust-launches-stock-offering-shares-down-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449773\" data-ts=\"1554924702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLXN\" target=\"_blank\">FLXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449773-flexion-down-13-on-departure-of-commercial-chief\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flexion down 13% on departure of commercial chief</a></h4><ul><li>Flexion Therapeutics (<a href='https://seekingalpha.com/symbol/FLXN' title='Flexion Therapeutics, Inc.'>FLXN</a> <font color=\"red\">-13.3%</font>) is down on more than a 6x surge in volume in apparent response to the unexpected departure of SVP of Commercial Operations Dan Deardorf. CEO Mark Clayman, M.D. apparently surprised the audience with the news during his presentation at Needham's Healthcare Conference today.</li><li>Mr. Deardorf's exit has unsettled investors with the Zilretta ramp, although the company reaffirmed its 2019 sales guidance of $65M - 80M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449773\" data-linked=\"Flexion down 13% on departure of commercial chief\" data-tweet=\"$FLXN - Flexion down 13% on departure of commercial chief https://seekingalpha.com/news/3449773-flexion-down-13-on-departure-of-commercial-chief?source=tweet\" data-url=\"https://seekingalpha.com/news/3449773-flexion-down-13-on-departure-of-commercial-chief\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449770\" data-ts=\"1554923333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROX\" target=\"_blank\">TROX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449770-ftc-settles-tronox-in-deal-for-cristals-titanium-dioxide-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FTC settles with Tronox in deal for Cristal&#39;s titanium dioxide business</a></h4><ul><li>Tronox (<a href='https://seekingalpha.com/symbol/TROX' title='Tronox Limited'>TROX</a> <font color=\"green\">+7.7%</font>) pops on news that the company <a href=\"https://www.ftc.gov/news-events/press-releases/2019/04/ftc-requires-divestitures-tronox-cristal-suppliers-widely-used\" target=\"_blank\">reached a settlement</a> with the Federal Trade Commission  that will allow it to proceed with its acquisition of much of Cristal\u2019s North American titanium dioxide assets.</li><li>According to the terms, Tronox agrees to sell Cristal's TiO2 facilities in Ashtabula, Ohio, which previously were valued at $700M; U.K. chemical company INEOS <a href=\"https://seekingalpha.com/news/3444067-tronox-plus-8-percent-ineos-buys-u-s-titanium-dioxide-business-700m\" target=\"_blank\">agreed last month</a> to buy the plants.</li><li>The FTC said in 2017 that it would go to court to block the deal, arguing that Tronox and Cristal were two of the three top suppliers of chloride process titanium dioxide; the third is Chemours (NYSE:<a href='https://seekingalpha.com/symbol/CC' title='The Chemours Company'>CC</a>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3449770\" data-linked=\"FTC settles with Tronox in deal for Cristal&#39;s titanium dioxide business\" data-tweet=\"$TROX $CC - FTC settles with Tronox in deal for Cristal&#39;s titanium dioxide business https://seekingalpha.com/news/3449770-ftc-settles-tronox-in-deal-for-cristals-titanium-dioxide-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3449770-ftc-settles-tronox-in-deal-for-cristals-titanium-dioxide-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449769\" data-ts=\"1554923064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAYO\" target=\"_blank\">ZAYO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449769-wells-fargo-zayo-worth-mid-thirties-per-share-in-buyout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo: Zayo worth mid-thirties per share in buyout</a></h4><ul>   <li><a href=\"https://seekingalpha.com/news/3449680-zayo-plus-7_3-percent-report-consortium-close-acquisition-deal\" target=\"_blank\">Reports of a bid for Zayo Group</a> (<a href=\"http://seekingalpha.com/symbol/ZAYO\" target=\"_blank\">ZAYO</a> <font color=\"green\">+5.5%</font>) value the company around $33.50-$37.50/share, Wells Fargo analyst Jennifer Fritzsche says.</li>    <li>A deal for $8B-$9B points to an EV/EBITDA multiple of 10.6x-11.3x, she says; while that might look disappointing compared to other fiber deals' 20x-30x multiples, it makes sense because of the size and complexity of Zayo's business. (h/t Bloomberg)</li>    <li>Shares are currently up to $31.07 today.</li>    <li>A mid-$30s buyout would offer P-E firms like the bidding consortium an IRR in the low to mid-teens.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449769\" data-linked=\"Wells Fargo: Zayo worth mid-thirties per share in buyout\" data-tweet=\"$ZAYO - Wells Fargo: Zayo worth mid-thirties per share in buyout https://seekingalpha.com/news/3449769-wells-fargo-zayo-worth-mid-thirties-per-share-in-buyout?source=tweet\" data-url=\"https://seekingalpha.com/news/3449769-wells-fargo-zayo-worth-mid-thirties-per-share-in-buyout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449767\" data-ts=\"1554922557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449767-technology-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong>Boxlight Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight Corporation'>BOXL</a>) <font color=\"green\">+15%</font>. Simulations Plus (NASDAQ:<a href='https://seekingalpha.com/symbol/SLP' title='Simulations Plus, Inc.'>SLP</a>) <font color=\"green\">+12%</font>. Eltek (NASDAQ:<a href='https://seekingalpha.com/symbol/ELTK' title='Eltek Ltd.'>ELTK</a>) <font color=\"green\">+11%</font>. Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"green\">+10%</font>. IZEA Worldwide (NASDAQ:<a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a>) <font color=\"green\">+11%</font>.</li> <li><strong>Losers: </strong>PAR Technology (NYSE:<a href='https://seekingalpha.com/symbol/PAR' title='PAR Technology Corporation'>PAR</a>) <font color=\"red\">-14%</font>. Atomera Incorporated (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOM' title='Atomera Incorporated'>ATOM</a>) <font color=\"red\">-10%</font>. Calix (NYSE:<a href='https://seekingalpha.com/symbol/CALX' title='Calix, Inc.'>CALX</a>) <font color=\"red\">-9%</font>. Lyft (NASDAQ:<a href='https://seekingalpha.com/symbol/LYFT' title='Lyft, Inc.'>LYFT</a>) <font color=\"red\">-9%</font>. SemiLEDs Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449767\" data-linked=\"Technology - Top 5 Gainers / Losers\" data-tweet=\"$BOXL $SLP $ELTK - Technology - Top 5 Gainers / Losers https://seekingalpha.com/news/3449767-technology-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449767-technology-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449759\" data-ts=\"1554921171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTM\" target=\"_blank\">TTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449759-tata-motors-rallies-to-2019-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tata Motors rallies to 2019 high</a></h4><ul> <li>Tata Motors (NYSE:<a href='https://seekingalpha.com/symbol/TTM' title='Tata Motors Limited'>TTM</a>) is <font color=\"green\">up 7.05%</font> is after the company <a href=\"https://www.tatamotors.com/press/tata-motors-group-global-wholesales-at-145459-in-march-2019/\" target=\"_blank\">updated</a> on global wholesales earlier in the day.</li> <li>Group global wholesales including Jaguar Land Rover fell 5% in March to 145,459 units.</li> <li>Global wholesales of all Tata Motors' commercial vehicles and Tata Daewoo range were up 1%.</li> <li>Jaguar wholesales were 20,985 units during the month and Land Rover wholesales were 49,186 units.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449759\" data-linked=\"Tata Motors rallies to 2019 high\" data-tweet=\"$TTM - Tata Motors rallies to 2019 high https://seekingalpha.com/news/3449759-tata-motors-rallies-to-2019-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3449759-tata-motors-rallies-to-2019-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449756\" data-ts=\"1554920081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GTE\" target=\"_blank\">GTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449756-gran-tierra-geopark-frontera-group-win-ecuador-oil-contracts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gran Tierra, GeoPark-Frontera group win Ecuador oil contracts</a></h4><ul><li>Gran Tierra Energy (<a href='https://seekingalpha.com/symbol/GTE' title='Gran Tierra Energy Inc.'>GTE</a> <font color='green'>+4.5%</font>), GeoPark (<a href='https://seekingalpha.com/symbol/GPRK' title='GeoPark Limited'>GPRK</a> <font color='green'>+0.3%</font>) and Frontera (<a href='https://seekingalpha.com/symbol/FECCF' title='Frontera Energy Corporation'>OTC:FECCF</a>) have <a href=\"https://www.nasdaq.com/article/gran-tierra-fronterageopark-consortium-win-ecuador-oil-contracts-20190410-00766\" target=\"_blank\">won bids to develop seven oil exploration blocks</a> with potentially high reserves in Ecuador, the country's energy ministry says.</li><li>GTE won contracts for the Chanangue, Charapa and Iguana blocks, while a consortium formed by Chile's GeoPark and Canada's Frontera will operate the Perico and Espejo blocks.</li><li>The ministry says development of the blocks will require an investment of $1.17B and allow an estimated peak production of 18K bbl/day in 2024.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449756\" data-linked=\"Gran Tierra, GeoPark-Frontera group win Ecuador oil contracts\" data-tweet=\"$GTE $GPRK $FECCF - Gran Tierra, GeoPark-Frontera group win Ecuador oil contracts https://seekingalpha.com/news/3449756-gran-tierra-geopark-frontera-group-win-ecuador-oil-contracts?source=tweet\" data-url=\"https://seekingalpha.com/news/3449756-gran-tierra-geopark-frontera-group-win-ecuador-oil-contracts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449750\" data-ts=\"1554919179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449750-baytex-energy-and-quintana-energy-services-among-energy-materials-gainers-foresight-energy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baytex Energy and Quintana Energy Services among Energy/Materials gainers; Foresight Energy and Sibanye Gold among losers</a></h4><ul><li><b>Gainers: </b>Baytex Energy (NYSE:<a href='https://seekingalpha.com/symbol/BTE' title='Baytex Energy Corp.'>BTE</a>) <font color=\"green\">+12%</font>. Quintana Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/QES' title='Quintana Energy Services Inc.'>QES</a>) <font color=\"green\">+11%</font>. Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+10%</font>. Crescent Point Energy (NYSE:<a href='https://seekingalpha.com/symbol/CPG' title='Crescent Point Energy Corp.'>CPG</a>) <font color=\"green\">+8%</font>. Parker Drilling (NYSE:<a href='https://seekingalpha.com/symbol/PKD' title='Parker Drilling Company'>PKD</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Foresight Energy (NYSE:<a href='https://seekingalpha.com/symbol/FELP' title='Foresight Energy LP'>FELP</a>) <font color=\"red\">-13%</font>. Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449750\" data-linked=\"Baytex Energy and Quintana Energy Services among Energy/Materials gainers; Foresight Energy and Sibanye Gold among losers\" data-tweet=\"$BTE $QES $AMRS - Baytex Energy and Quintana Energy Services among Energy/Materials gainers; Foresight Energy and Sibanye Gold among losers https://seekingalpha.com/news/3449750-baytex-energy-and-quintana-energy-services-among-energy-materials-gainers-foresight-energy?source=tweet\" data-url=\"https://seekingalpha.com/news/3449750-baytex-energy-and-quintana-energy-services-among-energy-materials-gainers-foresight-energy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449742\" data-ts=\"1554917548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAG\" target=\"_blank\">CAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449742-conagra-brandsplus-7-after-strong-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ConAgra Brands +7% after strong outlook</a></h4><ul> <li>ConAgra Brands (NYSE:<a href='https://seekingalpha.com/symbol/CAG' title='Conagra Brands, Inc.'>CAG</a>) <font color=\"green\">jumps 6.79%</font> after the company's analyst day event presentation pleases investors.</li> <li>Bank of America Merrill Lynch reiterates a Buy rating after taking in the update guidance from the food company. The BAML analyst team notes the outlook from ConAgra includes an expectation for free cash flow of $1.3B in 2022 and an upped synergy target.</li> <li>Shares of CAG are now up 35% YTD to rank first out of the 19 publicly-traded processed &amp; packaged good stocks with a market cap of over $50M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449699-highlights-conagra-brands-investor-presentation\" target=\"_blank\">Highlights from ConAgra Brands' investor presentation</a> (April 10)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449742\" data-linked=\"ConAgra Brands +7% after strong outlook\" data-tweet=\"$CAG - ConAgra Brands +7% after strong outlook https://seekingalpha.com/news/3449742-conagra-brandsplus-7-after-strong-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3449742-conagra-brandsplus-7-after-strong-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449739\" data-ts=\"1554916141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449739-atlanticus-holdings-leads-financial-gainers-loop-industries-and-severn-bancorp-only-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlanticus Holdings leads financial gainers; Loop Industries and Severn Bancorp only losers</a></h4><ul><li><b>Gainers:</b> Atlanticus Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ATLC' title='Atlanticus Holdings Corporation'>ATLC</a>) <font color=\"green\">+7%</font>. CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"green\">+6%</font>. Realogy Holdings (NYSE:<a href='https://seekingalpha.com/symbol/RLGY' title='Realogy Holdings Corp.'>RLGY</a>) <font color=\"green\">+5%</font>. China Bat Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='China Bat Group, Inc.'>GLG</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> Loop Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/LOOP' title='Loop Industries, Inc.'>LOOP</a>) <font color=\"red\">-6%</font>. Severn Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/SVBI' title='Severn Bancorp, Inc.'>SVBI</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449739\" data-linked=\"Atlanticus Holdings leads financial gainers; Loop Industries and Severn Bancorp only losers\" data-tweet=\"$ATLC $CBL $RLGY - Atlanticus Holdings leads financial gainers; Loop Industries and Severn Bancorp only losers https://seekingalpha.com/news/3449739-atlanticus-holdings-leads-financial-gainers-loop-industries-and-severn-bancorp-only-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449739-atlanticus-holdings-leads-financial-gainers-loop-industries-and-severn-bancorp-only-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449848\" data-ts=\"1554916011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TERP\" target=\"_blank\">TERP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449848-terraform-powerminus-4-goldman-cuts-to-sell-on-valuation-execution-risk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TerraForm Power -4% as Goldman cuts to Sell on valuation, execution risk</a></h4><ul><li>TerraForm Power (<a href='https://seekingalpha.com/symbol/TERP' title='TerraForm Power, Inc.'>TERP</a> <font color='red'>-3.8%</font>) tumbles after Goldman Sachs <a href=\"https://thefly.com/thestreet/realmoney/index.php/TERPid2890522/TERP-TerraForm-Power-downgraded-at-Goldman-Sachs-on-valuation-execution-risk\" target=\"_blank\">downgrades shares to Sell</a> from Neutral with a $12 price target, saying upside appears to have been priced in while the company is in the midst of an operational transition that may improve cash flow and dividend flexibility.</li><li>Goldman's Brian Lee also notes TERP's valuation has expanded to a 50 bps premium to the firm's \"yieldco group\" in spite of its industry-high leverage and that in the near term the company faces execution risk to wind production and the timing of cost realization.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449848\" data-linked=\"TerraForm Power -4% as Goldman cuts to Sell on valuation, execution risk\" data-tweet=\"$TERP - TerraForm Power -4% as Goldman cuts to Sell on valuation, execution risk https://seekingalpha.com/news/3449848-terraform-powerminus-4-goldman-cuts-to-sell-on-valuation-execution-risk?source=tweet\" data-url=\"https://seekingalpha.com/news/3449848-terraform-powerminus-4-goldman-cuts-to-sell-on-valuation-execution-risk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449737\" data-ts=\"1554915752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449737-global-brass-and-copper-leads-industrial-gainers-fuel-tech-and-research-frontiers-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Brass and Copper leads industrial gainers; Fuel Tech and Research Frontiers among losers</a></h4><ul><li><b>Gainers: </b>Global Brass and Copper (NYSE:<a href='https://seekingalpha.com/symbol/BRSS' title='Global Brass and Copper Holdings, Inc.'>BRSS</a>) <font color=\"green\">+25%</font>. Coda Octopus Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CODA' title='Coda Octopus Group, Inc.'>CODA</a>) <font color=\"green\">+10%</font>. The New Home Company (NYSE:<a href='https://seekingalpha.com/symbol/NWHM' title='The New Home Company Inc.'>NWHM</a>) <font color=\"green\">+6%</font>. China Recycling Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/CREG' title='China Recycling Energy Corporation'>CREG</a>) <font color=\"green\">+6%</font>. Legacy Housing (NASDAQ:<a href='https://seekingalpha.com/symbol/LEGH' title='Legacy Housing Corporation'>LEGH</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>MICT (NASDAQ:<a href='https://seekingalpha.com/symbol/MICT' title='MICT, Inc.'>MICT</a>) <font color=\"red\">-10%</font>. Fuel Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/FTEK' title='Fuel Tech, Inc.'>FTEK</a>) <font color=\"red\">-8%</font>. Research Frontiers (NASDAQ:<a href='https://seekingalpha.com/symbol/REFR' title='Research Frontiers Incorporated'>REFR</a>) <font color=\"red\">-7%</font>. Ryerson Holding (NYSE:<a href='https://seekingalpha.com/symbol/RYI' title='Ryerson Holding Corporation'>RYI</a>) <font color=\"red\">-7%</font>. Hudson Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HDSN' title='Hudson Technologies Inc.'>HDSN</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449737\" data-linked=\"Global Brass and Copper leads industrial gainers; Fuel Tech and Research Frontiers among losers\" data-tweet=\"$BRSS $CODA $NWHM - Global Brass and Copper leads industrial gainers; Fuel Tech and Research Frontiers among losers https://seekingalpha.com/news/3449737-global-brass-and-copper-leads-industrial-gainers-fuel-tech-and-research-frontiers-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3449737-global-brass-and-copper-leads-industrial-gainers-fuel-tech-and-research-frontiers-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449736\" data-ts=\"1554915719\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449736-discovery-and-youtube-reach-deal-for-live-on-demand-programs-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Discovery and YouTube reach deal for live, on-demand programs (updated)</a></h4><ul>   <li>Discovery (<a href=\"http://seekingalpha.com/symbol/DISCA\" target=\"_blank\">DISCA</a> <font color=\"green\">+6.1%</font>) and YouTube (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color=\"green\">+0.2%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color=\"green\">+0.1%</font>) have a multi-year agreement for live and on-demand distribution of programming.</li>    <li>Discovery shares have jumped to their highest point since November in response.</li>    <li>That brings Discovery's lifestyle brands to YouTube TV as of today: the Discovery Channel, HGTV, Food Network, TLC, Investigation Discovery, Animal Planet, Travel Channel, and MotorTrend. OWN (the Oprah Winfrey Network) will join them by the end of the year.</li>    <li>Along with live programming, YouTube TV subscribers will have video-on-demand content through YouTube's VOD service or by authenticating to the Discovery GO platform.</li><li><strong>Updated:</strong> And YouTube TV will <a href=\"https://www.thewrap.com/members/2019/04/10/youtube-tv-raises-price-to-50-per-month-following-content-agreement-with-discovery/\" target=\"_blank\">raise its monthly subscription fees</a> by 25%, to $50/month, following its agreement with Discovery.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449736\" data-linked=\"Discovery and YouTube reach deal for live, on-demand programs (updated)\" data-tweet=\"$GOOG $GOOGL $DISCA - Discovery and YouTube reach deal for live, on-demand programs (updated) https://seekingalpha.com/news/3449736-discovery-and-youtube-reach-deal-for-live-on-demand-programs-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3449736-discovery-and-youtube-reach-deal-for-live-on-demand-programs-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449733\" data-ts=\"1554915124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449733-bte-brss-wve-and-flxn-among-notable-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BTE, BRSS, WVE and FLXN among notable midday movers</a></h4><ul><li><strong>Gainers: </strong>Global Brass and Copper Holdings (NYSE:<a href='https://seekingalpha.com/symbol/BRSS' title='Global Brass and Copper Holdings, Inc.'>BRSS</a>) <font color=\"green\">+25%</font>. ATA (NASDAQ:<a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a>) <font color=\"green\">+22%</font>. Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"green\">+18%</font>. TDH Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a>) <font color=\"green\">+17%</font>. IZEA Worldwide (NASDAQ:<a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a>) <font color=\"green\">+16%</font>. Titan Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/TMDI' title='Titan Medical Inc.'>TMDI</a>) <font color=\"green\">+14%</font>. Baytex Energy (NYSE:<a href='https://seekingalpha.com/symbol/BTE' title='Baytex Energy Corp.'>BTE</a>) <font color=\"green\">+12%</font>. Quorum Health (NYSE:<a href='https://seekingalpha.com/symbol/QHC' title='Quorum Health Corporation'>QHC</a>) <font color=\"green\">+12%</font>. RigNet (NASDAQ:<a href='https://seekingalpha.com/symbol/RNET' title='RigNet, Inc.'>RNET</a>) <font color=\"green\">+11%</font>. Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) <font color=\"green\">+11%</font>.</li> <li><strong>Losers: </strong>Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"red\">-46%</font>. Wave Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences Ltd.'>WVE</a>) <font color=\"red\">-17%</font>. PAR Technology (NYSE:<a href='https://seekingalpha.com/symbol/PAR' title='PAR Technology Corporation'>PAR</a>) <font color=\"red\">-13%</font>. GEE Group (NYSEMKT:<a href='https://seekingalpha.com/symbol/JOB' title='GEE Group, Inc.'>JOB</a>) <font color=\"red\">-13%</font>. Flexion Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FLXN' title='Flexion Therapeutics, Inc.'>FLXN</a>) <font color=\"red\">-13%</font>. Foresight Energy (NYSE:<a href='https://seekingalpha.com/symbol/FELP' title='Foresight Energy LP'>FELP</a>) <font color=\"red\">-13%</font>. MICT (NASDAQ:<a href='https://seekingalpha.com/symbol/MICT' title='MICT, Inc.'>MICT</a>) <font color=\"red\">-11%</font>. Netshoes (NYSE:<a href='https://seekingalpha.com/symbol/NETS' title='Netshoes &#40;Cayman&#41; Limited'>NETS</a>) <font color=\"red\">-10%</font>. Caladrius Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLBS' title='Caladrius Biosciences, Inc.'>CLBS</a>) <font color=\"red\">-10%</font>. PolarityTE (NASDAQ:<a href='https://seekingalpha.com/symbol/PTE' title='PolarityTE, Inc.'>PTE</a>) <font color=\"red\">-9%</font>.<strong> </strong></li><strong> </strong></ul><div class=\"tiny-share-widget\" data-id=\"3449733\" data-linked=\"BTE, BRSS, WVE and FLXN among notable midday movers\" data-tweet=\"$BRSS $AACG $SFET - BTE, BRSS, WVE and FLXN among notable midday movers https://seekingalpha.com/news/3449733-bte-brss-wve-and-flxn-among-notable-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449733-bte-brss-wve-and-flxn-among-notable-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449729\" data-ts=\"1554913848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOCU\" target=\"_blank\">DOCU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449729-analysts-bullish-after-docusign-meeting-docuplus-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts bullish after DocuSign meeting; DOCU +5%</a></h4><ul><li>DocuSign (NASDAQ:<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a>) <font color=\"green\">gains 5.2%</font> after analysts affirmed bullish views following an investor meeting with DOCU's CFO.</li><li>William Blair (Outperform) left \"incrementally more bullish on the fundamentals\" and sees strong execution across all markets.</li><li>Deutsche Bank (Buy) thinks the Street is \"over-indexing\" the Adobe risk. The firm sees DOCU growing at 30%+ in FY20.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449729\" data-linked=\"Analysts bullish after DocuSign meeting; DOCU +5%\" data-tweet=\"$DOCU - Analysts bullish after DocuSign meeting; DOCU +5% https://seekingalpha.com/news/3449729-analysts-bullish-after-docusign-meeting-docuplus-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3449729-analysts-bullish-after-docusign-meeting-docuplus-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449727\" data-ts=\"1554913744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLP\" target=\"_blank\">SLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449727-simulations-plusplus-6-post-q2-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Simulations Plus +6% post Q2 earnings beat</a></h4><ul><li>Simulations Plus (<a href='https://seekingalpha.com/symbol/SLP' title='Simulations Plus, Inc.'>SLP</a> <font color=\"green\">+6.1%</font>) reported Q2 revenue growth of 15% Y/Y to $8.5M.</li><li>Revenue by division: Lancaster's $5M (+10% Y/Y); Buffalo's $2.3M (+22.8% Y/Y); and RTP in North Carolina's  $1.2M (+24.8% Y/Y).</li><li>Q2 Gross margin <font color=\"green\">improved by 270 bps</font> to 73.9%; and operating margin <font color=\"red\">declined by 63 bps</font> to 32.2%.</li><li>SG&amp;A expenses were $2.81M up by 20.1% Y/Y; and as percentage of revenue 33.2% up by 136 bps.</li><li>R&amp;D expenses were $724.03k up by 49.5% Y/Y.</li><li>Company has Cash and cash equivalents of $9.89M as of February 28, 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449486-simulations-plus-declares-0_06-dividend\" target=\"_blank\">Simulations Plus declares $0.06 dividend</a> (April 9)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449442-simulations-plus-beats-0_02-beats-revenue\" target=\"_blank\">Simulations Plus beats by $0.02, beats on revenue</a> (April 9)</li><li><a href=\"https://seekingalpha.com/article/4253648-simulations-plus-inc-slp-ceo-shawn-oconnor-q2-2019-results-earnings-call-transcript\" target=\"_blank\">Transcript</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3449727\" data-linked=\"Simulations Plus +6% post Q2 earnings beat\" data-tweet=\"$SLP - Simulations Plus +6% post Q2 earnings beat https://seekingalpha.com/news/3449727-simulations-plusplus-6-post-q2-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3449727-simulations-plusplus-6-post-q2-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449726\" data-ts=\"1554913345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOGI\" target=\"_blank\">LOGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449726-logitechplus-1_8-ceo-talks-big-acquisitions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Logitech +1.8% as CEO talks big acquisitions</a></h4><ul><li>Logitech (NASDAQ:<a href='https://seekingalpha.com/symbol/LOGI' title='Logitech International S.A.'>LOGI</a>) CEO Bracken Darrell tells <a href=\"https://www.handelszeitung.ch/unternehmen/vorab-das-bringt-die-neue-handelszeitung\" target=\"_blank\">Handelszeitung </a>that a big acquisition worth \"several billion Swiss Francs\" is \"conceivable.\"</li><li>Darrell stays vague by saying there could be \"four acqusitions, but also none\" but says any buy would have to accelerate and scale LOGI's existing business and provide new qualities.</li><li>Logitech shares are<font color=\"green\"> up 1.8%</font> to $40.96.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449726\" data-linked=\"Logitech +1.8% as CEO talks big acquisitions\" data-tweet=\"$LOGI - Logitech +1.8% as CEO talks big acquisitions https://seekingalpha.com/news/3449726-logitechplus-1_8-ceo-talks-big-acquisitions?source=tweet\" data-url=\"https://seekingalpha.com/news/3449726-logitechplus-1_8-ceo-talks-big-acquisitions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449718\" data-ts=\"1554912283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUYA\" target=\"_blank\">HUYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449718-huyaminus-4_5-on-follow-on-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HUYA -4.5% on follow-on offering</a></h4><ul><li>HUYA (NYSE:<a href='https://seekingalpha.com/symbol/HUYA' title='HUYA Inc.'>HUYA</a>) drops 4.5% after <a href=\"https://seekingalpha.com/filing/4440686\" target=\"_blank\">proposing</a> a follow-on offering of ADSs with the company offering 13.6M shares and selling holders offering 4.8M ADSs at $24 per share.</li><li>Underwriters will have a 30-day option to purchase an additional 2.04M shares from HUYA and 720K ADSs from the shareholders.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449718\" data-linked=\"HUYA -4.5% on follow-on offering\" data-tweet=\"$HUYA - HUYA -4.5% on follow-on offering https://seekingalpha.com/news/3449718-huyaminus-4_5-on-follow-on-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3449718-huyaminus-4_5-on-follow-on-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449716\" data-ts=\"1554912210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449716-conagra-brands-and-iconix-brand-group-among-consumer-gainers-niu-technologies-and-dogness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conagra Brands and Iconix Brand Group among consumer gainers; Niu Technologies and Dogness International in losers</a></h4><ul><li><b>Gainers: </b>TDH Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a>) <font color=\"green\">+17%</font>. Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) <font color=\"green\">+10%</font>. Levi Strauss &amp; Co (NYSE:<a href='https://seekingalpha.com/symbol/LEVI' title='Levi Strauss & Co.'>LEVI</a>) <font color=\"green\">+8%</font>. Conagra Brands (NYSE:<a href='https://seekingalpha.com/symbol/CAG' title='Conagra Brands, Inc.'>CAG</a>) <font color=\"green\">+7%</font>. Tempur Sealy International (NYSE:<a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International, Inc.'>TPX</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Niu Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NIU' title='Niu Technologies'>NIU</a>) <font color=\"red\">-7%. </font>Dogness International (NASDAQ:<a href='https://seekingalpha.com/symbol/DOGZ' title='Dogness &#40;International&#41; Corporation'>DOGZ</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449716\" data-linked=\"Conagra Brands and Iconix Brand Group among consumer gainers; Niu Technologies and Dogness International in losers\" data-tweet=\"$PETZ $ICON $LEVI - Conagra Brands and Iconix Brand Group among consumer gainers; Niu Technologies and Dogness International in losers https://seekingalpha.com/news/3449716-conagra-brands-and-iconix-brand-group-among-consumer-gainers-niu-technologies-and-dogness?source=tweet\" data-url=\"https://seekingalpha.com/news/3449716-conagra-brands-and-iconix-brand-group-among-consumer-gainers-niu-technologies-and-dogness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449714\" data-ts=\"1554911944\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDNA\" target=\"_blank\">CDNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449714-caredx-sues-natera-over-false-advertising\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CareDx sues Natera over false advertising</a></h4><ul><li>CareDx (<a href='https://seekingalpha.com/symbol/CDNA' title='CareDx, Inc'>CDNA</a> <font color=\"green\">+4.4%</font>) has filed a <a href=\"https://seekingalpha.com/pr/17472689-caredx-accuses-natera-false-advertising-claims-mislead-medical-personnel-transplant-patients\" target=\"_blank\">second lawsuit</a> against Natera (<a href='https://seekingalpha.com/symbol/NTRA' title='Natera, Inc.'>NTRA</a> <font color=\"green\">+3.7%</font>) accusing it of misleading doctors and patients about its kidney transplant technology compared to CDNA's AlloSure via its \"false advertising campaign\" claiming that its technology is superior to AlloSure.</li><li><a href=\"http://www.allosure.com/\" target=\"_blank\">AlloSure </a>is a non-invasive test that assesses the health of transplanted kidneys by measuring fragmented DNA in peripheral blood.</li><li>Natera's test, branded as <a href=\"https://www.natera.com/press-releases/medicare-issues-draft-local-coverage-determination-nateras-new-prospera%E2%84%A2-kidney\" target=\"_blank\">Prospera</a>, also assesses kidney transplant rejection via cell-free DNA in the blood.</li><li>CDNA seeks all available remedies including monetary damages.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449714\" data-linked=\"CareDx sues Natera over false advertising\" data-tweet=\"$CDNA $NTRA - CareDx sues Natera over false advertising https://seekingalpha.com/news/3449714-caredx-sues-natera-over-false-advertising?source=tweet\" data-url=\"https://seekingalpha.com/news/3449714-caredx-sues-natera-over-false-advertising\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449712\" data-ts=\"1554911896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STRL\" target=\"_blank\">STRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449712-sterling-awarded-21m-project-from-hawaii-department-of-transportation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sterling awarded ~$21M project from a Hawaii Department of Transportation</a></h4><ul><li>Sterling Construction\u2019s (<a href='https://seekingalpha.com/symbol/STRL' title='Sterling Construction Company, Inc.'>STRL</a> <font color=\"red\">-0.7%</font>) subsidiary, Road and Highway Builders, LLC has been <a href=\"https://seekingalpha.com/pr/17472343-sterling-awarded-hawaii-department-transportation-airport-project-valued-approximately-21\" target=\"_blank\">awarded</a> a $21M project from the Airports Division of the Hawaii Department of Transportation.</li><li>The project is to perform 40,000 tons of asphalt paving work on the runway at the Lanai Airport on the Hawaiian island of Lanai. Road and Highway Builders will also construct four concrete helicopter aprons.</li><li>The project is expected to begin in 4Q19 with a construction duration of ~6 months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449712\" data-linked=\"Sterling awarded ~$21M project from a Hawaii Department of Transportation\" data-tweet=\"$STRL - Sterling awarded ~$21M project from a Hawaii Department of Transportation https://seekingalpha.com/news/3449712-sterling-awarded-21m-project-from-hawaii-department-of-transportation?source=tweet\" data-url=\"https://seekingalpha.com/news/3449712-sterling-awarded-21m-project-from-hawaii-department-of-transportation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449706\" data-ts=\"1554910779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INPX\" target=\"_blank\">INPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449706-inpixon-to-acquire-locality-systems-inc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inpixon to acquire Locality Systems Inc.</a></h4><ul><li>Inpixon (<a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color=\"green\">+94.2%</font>) <a href=\"https://seekingalpha.com/pr/17472237-inpixon-leader-indoor-positioning-analytics-acquire-locality-systems-inc\" target=\"_blank\">signs</a> a non-binding term sheet to acquire Locality Systems Inc., a technology company based near Vancouver, Canada, specializing in wireless device positioning and radio frequency augmentation of video surveillance systems.</li><li>The acquisition is expected to be accretive and is anticipated to have a purchase price consisting of a combination of cash and equity.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449706\" data-linked=\"Inpixon to acquire Locality Systems Inc.\" data-tweet=\"$INPX - Inpixon to acquire Locality Systems Inc. https://seekingalpha.com/news/3449706-inpixon-to-acquire-locality-systems-inc?source=tweet\" data-url=\"https://seekingalpha.com/news/3449706-inpixon-to-acquire-locality-systems-inc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449701\" data-ts=\"1554910220\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCNI\" target=\"_blank\">CCNI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449701-command-centerplus-2_6-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Command Center +2.6% post Q4 results</a></h4><ul><li>Command Center (<a href='https://seekingalpha.com/symbol/CCNI' title='Command Center, Inc.'>CCNI</a> <font color=\"green\">+2.6%</font>) reports <a href=\"https://seekingalpha.com/pr/17471476-command-center-reports-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4</a> revenue decrease of 0.3% Y/Y to $24.44M.</li><li>Gross margin <font color=\"green\">increased by 260 bps</font> to 27.1%, due to fluctuations in the company\u2019s workers\u2019 compensation expense.</li><li>EBITDA margin <font color=\"green\">increased 374 bps</font> to 6.56%.</li><li>As a result of increased margin and lower SG&amp;A, income from operations increased by 116.7% Y/Y to $1.3M.</li><li>Cash and equivalents of $8M (+2.8% Y/Y).</li><li>During 2018, the company purchased ~324K shares of common stock through its share repurchase program at an aggregate price of ~$1.8M for average price of $5.65/share.</li><li>As of December 28, 2018, ~$2.8M remains under the current repurchase program.</li><li>\u201cIn addition to favorable workers\u2019 compensation accrual adjustments compared to previous periods, the $1.2M improvement in net income demonstrates our progress in streamlining operations and improving operating efficiency.\u201d said Rick Coleman, President and CEO of Command Center.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449428-command-center-reports-q4-results\" target=\"_blank\">Command Center reports Q4 results</a> (Apr. 09 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3449701\" data-linked=\"Command Center +2.6% post Q4 results\" data-tweet=\"$CCNI - Command Center +2.6% post Q4 results https://seekingalpha.com/news/3449701-command-centerplus-2_6-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3449701-command-centerplus-2_6-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449702\" data-ts=\"1554910054\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449702-kb-homeplus-1_3-pultegroupplus-0_7-after-jpmorgan-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Home +1.3%, PulteGroup +0.7% after JPMorgan upgrades</a></h4><ul><li>KBHome (NYSE:<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a>) and PulteGroup (NYSE:<a href='https://seekingalpha.com/symbol/PHM' title='PulteGroup, Inc.'>PHM</a>) are <a href=\"https://www.cnbc.com/2019/04/10/calls-of-the-day-apple-disney-more.html\" target=\"_blank\">raised</a> to neutral from underweight by JPMorgan, recognizing more stable demand as mortgage rates continue to decline.</li><li>Boosts December 2019 price targets for Pulte by 6% and for KB by 12%.</li><li>Says \"positive momentum\" likely to continue in the near-term for the sector.</li><li>Still \"hesitant to ascribe target multiples that are greater than prior mid-cycle valuations.\"</li><li>JPMorgan's 2020 EPS estimates stay 5%-10% or more below Street consensus for several names in the sector.</li><li><a href=\"https://seekingalpha.com/symbol/KBH/earnings/analyst_ratings\" target=\"_blank\">KBH analyst ratings</a>; <a href=\"https://seekingalpha.com/symbol/PHM/earnings/analyst_ratings\" target=\"_blank\">PHM analyst ratings</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449702\" data-linked=\"KB Home +1.3%, PulteGroup +0.7% after JPMorgan upgrades\" data-tweet=\"$KBH $PHM - KB Home +1.3%, PulteGroup +0.7% after JPMorgan upgrades https://seekingalpha.com/news/3449702-kb-homeplus-1_3-pultegroupplus-0_7-after-jpmorgan-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3449702-kb-homeplus-1_3-pultegroupplus-0_7-after-jpmorgan-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449698\" data-ts=\"1554909423\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BILI\" target=\"_blank\">BILI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449698-bilibili-adds-bull-on-mau-growth-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bilibili adds bull on MAU growth potential</a></h4><ul><li>UBS starts Bilibili (<a href='https://seekingalpha.com/symbol/BILI' title='Bilibili Inc.'>BILI</a> <font color='red'>-1.9%</font>) at Buy and a $23 price target saying the \"uniquely positioned\" company could nearly double its MAU base from 112M this year to 210M in 2023.</li><li>The firm expects Generation Z user penetration to grow from the current 30% to 50% over time.</li><li>UBS says BILI is in an early stage for monetization and has a higher chance than its peers to develop multiple growth drivers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449698\" data-linked=\"Bilibili adds bull on MAU growth potential\" data-tweet=\"$BILI - Bilibili adds bull on MAU growth potential https://seekingalpha.com/news/3449698-bilibili-adds-bull-on-mau-growth-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3449698-bilibili-adds-bull-on-mau-growth-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449689\" data-ts=\"1554908484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449689-geron-and-transenterix-among-healthcare-gainers-polarityte-and-wave-life-sciences-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Geron and TransEnterix among healthcare gainers; PolarityTE and Wave Life Sciences  among losers</a></h4><ul><li><b>Gainers: </b>AzurRx BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/AZRX' title='AzurRx BioPharma, Inc.'>AZRX</a>) <font color=\"green\">+10%</font>. Geron (NASDAQ:<a href='https://seekingalpha.com/symbol/GERN' title='Geron Corporation'>GERN</a>) <font color=\"green\">+9%</font>. Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics, Inc.'>MLNT</a>) <font color=\"green\">+8%</font>. Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <font color=\"green\">+8%</font>. TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"red\">-47%</font>. Wave Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences Ltd.'>WVE</a>) <font color=\"red\">-17%</font>. PolarityTE (NASDAQ:<a href='https://seekingalpha.com/symbol/PTE' title='PolarityTE, Inc.'>PTE</a>) <font color=\"red\">-10%</font>. Genprex (NASDAQ:<a href='https://seekingalpha.com/symbol/GNPX' title='Genprex, Inc.'>GNPX</a>) <font color=\"red\">-8%</font>. Establishment Labs Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ESTA' title='Establishment Labs Holdings Inc.'>ESTA</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449689\" data-linked=\"Geron and TransEnterix among healthcare gainers; PolarityTE and Wave Life Sciences  among losers\" data-tweet=\"$AZRX $GERN $MLNT - Geron and TransEnterix among healthcare gainers; PolarityTE and Wave Life Sciences among losers https://seekingalpha.com/news/3449689-geron-and-transenterix-among-healthcare-gainers-polarityte-and-wave-life-sciences-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3449689-geron-and-transenterix-among-healthcare-gainers-polarityte-and-wave-life-sciences-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449686\" data-ts=\"1554908175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CFRX\" target=\"_blank\">CFRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449686-contrafect-adds-to-cfminus-301-stoked-rally-up-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ContraFect adds to CF-301-stoked rally, up 18%</a></h4><ul><li>Nano cap ContraFect (<a href='https://seekingalpha.com/symbol/CFRX' title='ContraFect Corporation'>CFRX</a> <font color=\"green\">+18.1%</font>) is up on triple normal volume. Shares have rallied about <font color=\"green\">60%</font> this month.</li><li>On Monday, April 8, it <a href=\"https://seekingalpha.com/pr/17468734-contrafect-announces-publication-exebacase-data-antimicrobial-agents-chemotherapy-journal\" target=\"_blank\">announced </a>the publication of a manuscript in a peer-reviewed journal on lead candidate CF-301 for the potential treatment of methicillin-resistant <em>Staphylococcus aureus</em> &#40;MRSA&#41; infection in the bloodstream.</li><li>The manuscript highlights the activity of <a href=\"https://www.contrafect.com/pipeline/cf-301\" target=\"_blank\">CF-301</a> (exebacase), a bacteriophage-derived enzyme called a lysin, which showed its substantially higher potency (32x - more than 100x) in human blood compared to a conventional testing medium, demonstrating \"synergistic interaction\" with two key human blood factors, activity that supports its mechanism of action.</li><li>A <a href=\"https://clinicaltrials.gov/ct2/show/NCT03163446?lead=contrafect&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> in patients with <em>S. aureus</em> bacteremia should be winding up shortly.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449686\" data-linked=\"ContraFect adds to CF-301-stoked rally, up 18%\" data-tweet=\"$CFRX - ContraFect adds to CF-301-stoked rally, up 18% https://seekingalpha.com/news/3449686-contrafect-adds-to-cfminus-301-stoked-rally-up-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3449686-contrafect-adds-to-cfminus-301-stoked-rally-up-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449681\" data-ts=\"1554907803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEVI\" target=\"_blank\">LEVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449681-levi-strauss-up-4-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Levi Strauss up 4% post Q1 results</a></h4><ul><li>Levi Strauss (<a href='https://seekingalpha.com/symbol/LEVI' title='Levi Strauss & Co.'>LEVI</a> <font color=\"green\">+4.6%</font>) reported Q1 revenue growth of 7% Y/Y to $1.44B, with growth across all regions; and constant currency +11% Y/Y.</li><li>Regional sales: Americas $717M (+9% Y/Y); Europe $465M (+3% Y/Y) and Asia $253M (+8% Y/Y).</li><li>Q1 Gross margin <font color=\"red\">declined by 30 bps</font> to 54.6%; and operating margin <font color=\"green\">improved by 100 bps</font> to 14%.</li><li>Adj. EBITDA increased 10.2% Y/Y to $234.9M; and margin <font color=\"green\">improved by 52 bps</font> to 16.4%.</li><li>SG&amp;A expenses were $581.89M up by 3.3% Y/Y.</li><li>Cash from operations was $56M, compared to $66.17M a year ago; and Adj. free cash flow was $17M.</li><li>FY19 Guidance: Company expects constant-currency net revenues growth of mid-single digits;constant-currency Adj. EBIT margin flat-to-slightly up; and capital expenditures of ~$190M - $200M and anticipates nearly 100 new company-operated store openings in FY19.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449441-levi-strauss-reports-q1-results\" target=\"_blank\">Levi Strauss reports Q1 results</a> (April 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3449681\" data-linked=\"Levi Strauss up 4% post Q1 results\" data-tweet=\"$LEVI - Levi Strauss up 4% post Q1 results https://seekingalpha.com/news/3449681-levi-strauss-up-4-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3449681-levi-strauss-up-4-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449682\" data-ts=\"1554907799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIL\" target=\"_blank\">SAIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449682-sailpoint-appoints-chief-information-security-officer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SailPoint appoints Chief Information Security Officer</a></h4><ul><li>SailPoint Technologies (<a href='https://seekingalpha.com/symbol/SAIL' title='SailPoint Technologies Holdings, Inc.'>SAIL</a> <font color='green'>+1.8%</font>) <a href=\"https://seekingalpha.com/pr/17472333-sailpoint-names-charles-poff-chief-information-security-officer\" target=\"_blank\">appoints </a>Charles Poff as Chief Information Security Officer.</li><li>Poff joins the company after nearly a decade at HomeAway where he led the security program.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449682\" data-linked=\"SailPoint appoints Chief Information Security Officer\" data-tweet=\"$SAIL - SailPoint appoints Chief Information Security Officer https://seekingalpha.com/news/3449682-sailpoint-appoints-chief-information-security-officer?source=tweet\" data-url=\"https://seekingalpha.com/news/3449682-sailpoint-appoints-chief-information-security-officer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449680\" data-ts=\"1554907482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAYO\" target=\"_blank\">ZAYO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449680-zayoplus-7_3-on-report-consortium-is-close-to-acquisition-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zayo +7.3% on report consortium is close to acquisition deal</a></h4><ul>   <li>Zayo Group (NYSE:<a href='https://seekingalpha.com/symbol/ZAYO' title='Zayo Group Holdings, Inc.'>ZAYO</a>) has <font color=\"green\">jumped 7.3%</font> on a Reuters report that a consortium featuring Digital Colony Partners, EQT and Stonepeak are <a href=\"https://www.reuters.com/article/us-zayo-m-a-digitalcolony-exclusive/exclusive-eqt-digital-colony-stonepeak-group-near-deal-to-buy-zayo-sources-say-idUSKCN1RM1XH?il=0\" target=\"_blank\">close to a deal to buy the provider</a>.</li>    <li>The consortium has exclusive rights to negotiate a deal after presenting an attractive enough offer, the report says, and that deal would value Zayo between $8B-$9B excluding $5.9B in debt.</li>    <li>The deal if consummated could be announced later this month.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448221-zayo-plus-4-percent-report-sale-process-moving-multiple-bidders\" target=\"_blank\">Zayo +4% on report sale process moving with multiple bidders</a> (Apr. 03 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449680\" data-linked=\"Zayo +7.3% on report consortium is close to acquisition deal\" data-tweet=\"$ZAYO - Zayo +7.3% on report consortium is close to acquisition deal https://seekingalpha.com/news/3449680-zayoplus-7_3-on-report-consortium-is-close-to-acquisition-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3449680-zayoplus-7_3-on-report-consortium-is-close-to-acquisition-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449674\" data-ts=\"1554907004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVIO\" target=\"_blank\">EVIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449674-evio-updates-on-equity-financing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EVIO updates on equity financing</a></h4><ul> <li>EVIO (<a href='https://seekingalpha.com/symbol/EVIO' title='EVIO, Inc.'>OTCQB:EVIO</a> <font color='red'>-9%</font>) announces that it closed an initial tranche in its unit offering for an aggregate amount of $586K.</li><li>The company says the bulk of the offering was completed on a best efforts basis through lead agent/bookrunner Dominick Capital Corporation.</li>   <li>Offering terms: Each unit consists of one share of EVIO common stock at a price of $0.40, and a share purchase warrant in the amount of one full warrant per unit. Each whole warrant shall entitles the holder to purchase one additional share of the offeror  at an exercise price of $0.65 per warrant share for a period of 24 months after the closing of the offering.</li>  <li>EVIO plans to use the proceeds of the offering in part to complete the relocation and improvements to its Massachusetts laboratory operations and to improve infrastructure at its Keystone Labs facility in Edmonton, Alberta.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17472613-evio-inc-closes-first-tranche-equity-financing\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3449674\" data-linked=\"EVIO updates on equity financing\" data-tweet=\"$EVIO - EVIO updates on equity financing https://seekingalpha.com/news/3449674-evio-updates-on-equity-financing?source=tweet\" data-url=\"https://seekingalpha.com/news/3449674-evio-updates-on-equity-financing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449672\" data-ts=\"1554906774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449672-oil-inventories-build-sharply\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil inventories build sharply</a></h4><ul><li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories:</a> Crude <strong>+</strong><strong>7.0</strong><strong>M</strong> barrels vs. +2.3M consensus, +7.2M last week.</li><li>Gasoline <strong>-7.7M</strong> barrels vs. -2.0M consensus, -1.8M last week.</li><li>Distillates<strong> -0.1</strong><strong>M</strong> barrels vs. -1.3M consensus, -2.0M last week.</li><li>Futures <font color=\"green\">+0.64%</font> to $64.39.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449672\" data-linked=\"Oil inventories build sharply\" data-tweet=\"$USO $OIL $UCO - Oil inventories build sharply https://seekingalpha.com/news/3449672-oil-inventories-build-sharply?source=tweet\" data-url=\"https://seekingalpha.com/news/3449672-oil-inventories-build-sharply\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449671\" data-ts=\"1554906754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449671-intelsat-shares-drop-amid-satellite-service-outage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelsat shares drop amid satellite service outage</a></h4><ul>   <li>Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat S.A.'>I</a>) is reporting an <a href=\"https://seekingalpha.com/pr/17472609-intelsat-reports-intelsat-29e-service-outage\" target=\"_blank\">ongoing service outage</a> on its Intelsat 29e satellite that's disrupting communications for maritime, aeronautical and wireless operators in Latin America, the Caribbean and North Atlantic.</li>    <li>The satellite's propulsion system experienced damage that caused a propellant leak on April 7, the company says. While working to restore service yesterday, the satellite experienced a second anomaly, and communication with the satellite has been intermittent.</li>    <li>The company says it's still working with the satellite's manufacturer, Boeing (<a href=\"http://seekingalpha.com/symbol/BA\" target=\"_blank\">BA</a> <font color=\"red\">-1.2%</font>) on recovering communication, and in the meantime is migrating services to other satellites and third-party services.</li>    <li>Intelsat shares are <font color=\"red\">down 1.7%</font> now after dropping as much as 10% a short while ago.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3449671\" data-linked=\"Intelsat shares drop amid satellite service outage\" data-tweet=\"$I $BA - Intelsat shares drop amid satellite service outage https://seekingalpha.com/news/3449671-intelsat-shares-drop-amid-satellite-service-outage?source=tweet\" data-url=\"https://seekingalpha.com/news/3449671-intelsat-shares-drop-amid-satellite-service-outage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449665\" data-ts=\"1554906276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449665-investors-apply-full-court-pressure-on-bed-bath-beyond\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors apply full-court pressure on Bed Bath &amp; Beyond</a></h4><ul> <li>A group of Bed Bath &amp; Beyond (<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a> <font color='green'>+1.8%</font>) investors are calling on the retailer's board and management team to increase the level of       disclosure and transparency when it reports Q4 results later today.</li>     <li>In particular, the investors want to know what are the same-store sales, revenues, online sales, gross margins,       operating margins, capital expenditures, depreciation, assets and square       footage broken out by each of the larger business concepts (Bed Bath &amp;       Beyond, Cost Plus World Markets, buybuy BABY, Christmas Tree Shops,       and That! and Harmon)?</li>          <li>Also of interest is a clarification on the 500-basis point deterioration in gross margin       since 2013. How much is attributable to mix shift, promotional activity,       lower AUR, increased clearance and changes in initial mark-up?</li><li>And what specific performance can the management point to that explains       why they are \"ahead of plan\"?</li><li>Investors participating in the BBBY full-court press include Legion Partners Holdings, Macellum Advisors and Ancora Advisors.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17471510-investor-group-calls-increased-transparency-bed-bath-and-beyond-q4-earnings-call\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3449665\" data-linked=\"Investors apply full-court pressure on Bed Bath &amp; Beyond\" data-tweet=\"$BBBY - Investors apply full-court pressure on Bed Bath &amp; Beyond https://seekingalpha.com/news/3449665-investors-apply-full-court-pressure-on-bed-bath-beyond?source=tweet\" data-url=\"https://seekingalpha.com/news/3449665-investors-apply-full-court-pressure-on-bed-bath-beyond\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449664\" data-ts=\"1554906226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNA\" target=\"_blank\">SNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449664-snap-on-slides-on-downgrade-baird\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap-On slides on downgrade at Baird</a></h4><ul><li>Snap-On (NYSE:<a href='https://seekingalpha.com/symbol/SNA' title='Snap-on Incorporated'>SNA</a>) <font color=\"red\">slips 3.2%</font> in early trade after Baird <a href=\"https://www.streetinsider.com/Analyst+Comments/Baird+Downgrades+Snap-On+%28SNA%29+to+Neutral/15356728.html\" target=\"_blank\">downgraded</a> the stock to Neutral from Outperform and lowered its price target on shares to $160 from $186.</li><li>There are more near-term performance challenges, according to the firm, and until growth improves, shares will be range-bound as the bull/bear debate continues.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449664\" data-linked=\"Snap-On slides on downgrade at Baird\" data-tweet=\"$SNA - Snap-On slides on downgrade at Baird https://seekingalpha.com/news/3449664-snap-on-slides-on-downgrade-baird?source=tweet\" data-url=\"https://seekingalpha.com/news/3449664-snap-on-slides-on-downgrade-baird\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449659\" data-ts=\"1554905472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UIS\" target=\"_blank\">UIS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449659-unisys-gains-cfo-resigns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Unisys gains as CFO resigns</a></h4><ul><li>Unisys (<a href='https://seekingalpha.com/symbol/UIS' title='Unisys Corporation'>UIS</a> <font color='green'>+1.3%</font>) <a href=\"https://seekingalpha.com/pr/17472057-unisys-announces-resignation-chief-financial-officer-inder-m-singh-appointment-controller\" target=\"_blank\">announces</a> that CFO Inder Singh will resign to join another company, effective April 26.</li><li>Mike Thomson, corporate controller and principal accounting officer, will serve as interim CFO.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449659\" data-linked=\"Unisys gains as CFO resigns\" data-tweet=\"$UIS - Unisys gains as CFO resigns https://seekingalpha.com/news/3449659-unisys-gains-cfo-resigns?source=tweet\" data-url=\"https://seekingalpha.com/news/3449659-unisys-gains-cfo-resigns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449656\" data-ts=\"1554904921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449656-jpmorgan-cuts-boeing-pt-earnings-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan cuts Boeing PT, earnings outlook</a></h4><ul><li>Boeing (NYSE:<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a>) shares are<font color=\"red\"> 1.1% lower</font> in early trade, marking a fourth-straight session decline, after JPMorgan analyst Seth Seifman <a href=\"https://www.marketwatch.com/story/boeings-stock-slips-after-jp-morgan-cuts-price-target-earnings-outlook-2019-04-10?siteid=yhoof2&amp;yptr=yahoo\" target=\"_blank\">cut</a> his price target to $430 (from $450) following yesterday's Q1 deliveries data.</li><li>He also reduced his 2019 adjusted EPS estimate to $19.35 from $20.60 and his 2020 forecast to $22.30 from $23.50.</li><li>Seifman's general view remains positive, however, and he reiterated an Overweight rating.</li><li>\"At this stage, modeling Boeing requires major assumptions for which there is little basis right now. Boeing is among the companies best positioned to benefit from positive aero fundamentals, in our view, and the company is consciously trying to shape the industry to capture more value for itself, which could mean strong relative performance and potential upside to estimates.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3449656\" data-linked=\"JPMorgan cuts Boeing PT, earnings outlook\" data-tweet=\"$BA - JPMorgan cuts Boeing PT, earnings outlook https://seekingalpha.com/news/3449656-jpmorgan-cuts-boeing-pt-earnings-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3449656-jpmorgan-cuts-boeing-pt-earnings-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449651\" data-ts=\"1554904564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLOB\" target=\"_blank\">GLOB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449651-globantplus-3_4-on-new-bull\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globant +3.4% on new bull</a></h4><ul><li>Morgan Stanley starts Globant (NYSE:<a href='https://seekingalpha.com/symbol/GLOB' title='Globant S.A.'>GLOB</a>) at Overweight with a PT of $85, implying an 11% upside.</li><li>Globant is expected to report earnings on May 9. Analysts estimate $145.14M in revenue and $0.47 EPS.</li><li>GLOB shares are <font color=\"green\">up 3.4%</font> to $79.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449651\" data-linked=\"Globant +3.4% on new bull\" data-tweet=\"$GLOB - Globant +3.4% on new bull https://seekingalpha.com/news/3449651-globantplus-3_4-on-new-bull?source=tweet\" data-url=\"https://seekingalpha.com/news/3449651-globantplus-3_4-on-new-bull\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449646\" data-ts=\"1554904151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADSK\" target=\"_blank\">ADSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449646-autodesk-reinstated-overweightplus-1_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autodesk reinstated at Overweight; +1.6%</a></h4><ul><li>Autodesk (NASDAQ:<a href='https://seekingalpha.com/symbol/ADSK' title='Autodesk, Inc.'>ADSK</a>) <font color=\"green\">gains 1.6%</font> following KeyBanc's after hours reinstatement at Overweight and a PT of $196, implying a 17% upside.</li><li>Late last month, Autodesk <a href=\"https://seekingalpha.com/pr/17458065-autodesk-reaffirms-first-quarter-fiscal-year-2020-outlook-annual-investor-day\" target=\"_blank\">reaffirmed</a> its Q1 and FY20 outlook. Q1 has $735M to $745M in revenue and $0.44 to $0.48 EPS. The FY20 outlook missed estimates with EPS from $2.71 to $2.90 (consensus of $2.85 missed at midpoint) and revenue from $3.25B to $3.3B (consensus of $3.29B missed at midpoint).</li><li>Autodesk is expected to report earnings on May 23. For the quarter, analysts <a href=\"https://seekingalpha.com/symbol/ADSK/earnings\" target=\"_blank\">estimate</a> $739.97M in revenue and $0.47 EPS.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449646\" data-linked=\"Autodesk reinstated at Overweight; +1.6%\" data-tweet=\"$ADSK - Autodesk reinstated at Overweight; +1.6% https://seekingalpha.com/news/3449646-autodesk-reinstated-overweightplus-1_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3449646-autodesk-reinstated-overweightplus-1_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449644\" data-ts=\"1554903960\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449644-t-mobile-unveils-tvision-home-tv-service-for-eight-markets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile unveils TVision Home TV service for eight markets</a></h4><ul>   <li>T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"green\">+0.4%</font>) has rebranded its Layer3 television product as <a href=\"https://seekingalpha.com/pr/17472449-meet-t-mobile-tvision-home-bs-free-tv-learns\" target=\"_blank\">TVision Home</a>, an upgraded offering it's rolling out in eight markets.</li>    <li>It's set for launch April 14 in Chicago, Dallas-Fort Worth, Los Angeles, New York, Philadelphia, San Francisco, Washington, D.C., and Longmont, Colo.</li>    <li>In a deal it calls \"Satellite Freedom,\" it's offering to pay off early termination fees for those switching from Dish Network (<a href=\"http://seekingalpha.com/symbol/DISH\" target=\"_blank\">DISH</a> <font color=\"green\">+1.6%</font>) and DirecTV (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"green\">+0.8%</font>).</li>    <li>T-Mobile plans to launch nationwide streaming services later this year.</li>    <li>And TVision Home will have other streaming services available on the platform: It's announced a deal with Amazon.com (<a href=\"http://seekingalpha.com/symbol/AMZN\" target=\"_blank\">AMZN</a> <font color=\"green\">+0.1%</font>) to <a href=\"https://seekingalpha.com/pr/17472477-t-mobile-amazon-bring-prime-video-tvision-home\" target=\"_blank\">bring Prime Video</a> on board later this year, and will offer Netflix and other popular apps.</li>    <li>The FCC resumed its review of T-Mobile's proposed merger with Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"green\">+0.2%</font>) last week; it's on day 128 of a 180-day review.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449644\" data-linked=\"T-Mobile unveils TVision Home TV service for eight markets\" data-tweet=\"$TMUS $DISH $T - T-Mobile unveils TVision Home TV service for eight markets https://seekingalpha.com/news/3449644-t-mobile-unveils-tvision-home-tv-service-for-eight-markets?source=tweet\" data-url=\"https://seekingalpha.com/news/3449644-t-mobile-unveils-tvision-home-tv-service-for-eight-markets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449639\" data-ts=\"1554903457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FORM\" target=\"_blank\">FORM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449639-formfactor-gets-street-high-target-on-momentum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FormFactor gets Street-high target on momentum</a></h4><ul><li>D.A. Davidson reiterates a Buy rating on FormFactor (NASDAQ:<a href='https://seekingalpha.com/symbol/FORM' title='FormFactor, Inc.'>FORM</a>) and raises its PT from $18 to the Street-high $21 citing increasing momentum \"across several growth vectors.\"</li><li>The firm is \"increasingly bullish\" on FORM's growth prospects and the potential for significant outperformance versus its peers over the next few years.</li><li>D.A. Davidson says meetings with management made it clear that the \"timing and magnitude of FORM\u2019s unique business drivers are sooner and larger\" than the firm expected.</li><li>FORM shares are <font color=\"green\">up 0.8%</font> to $18.10.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449639\" data-linked=\"FormFactor gets Street-high target on momentum\" data-tweet=\"$FORM - FormFactor gets Street-high target on momentum https://seekingalpha.com/news/3449639-formfactor-gets-street-high-target-on-momentum?source=tweet\" data-url=\"https://seekingalpha.com/news/3449639-formfactor-gets-street-high-target-on-momentum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449638\" data-ts=\"1554903407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRNE\" target=\"_blank\">SRNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449638-sorrento-up-6-on-encouraging-resiniferatoxin-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sorrento up 6% on encouraging resiniferatoxin data</a></h4><ul><li>Sorrento Therapeutics (<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color=\"green\">+6.4%</font>) is up out of the gate this morning on the heels of results from a <a href=\"https://seekingalpha.com/pr/17472402-sorrento-therapeutics-announces-discovery-potential-non-dopaminergic-approach-controlling\" target=\"_blank\">discovery study</a> in a rodent model exploring the potential effect of resiniferatoxin &#40;RTX&#41; in controlling neuro-inflammatory processes associated with Parkinson's disease &#40;PD&#41;.</li><li>Intrathecal (injection into the spinal canal) administration of RTX produced \"profoundly improved\" motor function compared to vehicle (placebo) at day 7. No significant effects in levels of dopamine or its metabolites in an area in the brain called the <a href=\"https://neuroscientificallychallenged.com/blog/know-your-brain-striatum\" target=\"_blank\">striatum</a> were observed.</li><li>Complete data will be published in a major scientific journal and will be submitted for presentation at an upcoming neurosciences conference later this year.</li><li>Preclinical activities are ongoing. If these results are confirmed, human trials will be next.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449638\" data-linked=\"Sorrento up 6% on encouraging resiniferatoxin data\" data-tweet=\"$SRNE - Sorrento up 6% on encouraging resiniferatoxin data https://seekingalpha.com/news/3449638-sorrento-up-6-on-encouraging-resiniferatoxin-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3449638-sorrento-up-6-on-encouraging-resiniferatoxin-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449632\" data-ts=\"1554902953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449632-new-ev-bill-expected-to-be-pitched-in-dc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New EV bill expected to be pitched in DC</a></h4><ul> <li>New legislation is expected to be introduced by a group of  bipartisan lawmakers today to <a href=\"https://www.reuters.com/article/us-autos-electric-taxcredit-exclusive/exclusive-u-s-lawmakers-introduce-bill-to-boost-electric-car-tax-credits-idUSKCN1RM1NG\" target=\"_blank\">expand</a> the electric vehicle tax credit by 400K vehicles per manufacturer, according to Reuters.</li> <li>The \"Driving America Forward Act\" would give each automaker a $7K tax credit for an additional 400K vehicles in addition to the current 200K vehicles eligible for the $7.5K tax credits. The phase-out period would be shortened to nine months. The legislation would also extend the hydrogen fuel cell credit through 2028.</li> <li>The bill is sponsored by Democratic Senators Debbie Stabenow and Gary Peters, Republican Senators Lamar Alexander and Susan Collins and Democratic Representative Dan Kildee.</li> <li>Shares of Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) are <font color=\"green\">up 1.92%</font> in premarket trading, while General Motors (NYSE:<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a>) is <font color=\"green\">0.65% higher</font>.</li> <li>Related stocks: <a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>, <a href='https://seekingalpha.com/symbol/TM' title='Toyota Motor Corporation'>TM</a>, <a href='https://seekingalpha.com/symbol/HMC' title='Honda Motor Co., Ltd.'>HMC</a>, <a href='https://seekingalpha.com/symbol/NSANY' title='Nissan Motor Co., Ltd.'>OTCPK:NSANY</a>, <a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles N.V.'>FCAU</a>, <a href='https://seekingalpha.com/symbol/HYMLF' title='Hyundai Motor Company'>OTCPK:HYMLF</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3449632\" data-linked=\"New EV bill expected to be pitched in DC\" data-tweet=\"$TSLA $GM $F - New EV bill expected to be pitched in DC https://seekingalpha.com/news/3449632-new-ev-bill-expected-to-be-pitched-in-dc?source=tweet\" data-url=\"https://seekingalpha.com/news/3449632-new-ev-bill-expected-to-be-pitched-in-dc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>810&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449630\" data-ts=\"1554902691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LBTYA\" target=\"_blank\">LBTYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449630-liberty-globalminus-2_9-bofaml-cuts-to-underperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liberty Global -2.9% as BofAML cuts to Underperform</a></h4><ul>   <li>Liberty Global (NASDAQ:<a href='https://seekingalpha.com/symbol/LBTYA' title='Liberty Global Plc'>LBTYA</a>) is <font color=\"red\">2.9% lower</font> premarket after a downgrade to Underperform at BofA Merrill Lynch, which sees growth fading after some asset sales.</li>    <li>A large cash pile is \"unlikely to reignite investor interest\" and opportunities to restart momentum through M&amp;A look limited, analyst David Wright says; cash could be used to pay down debt or buy back shares.</li>    <li>He's cut his price target to $23.50 from $38.60, implying 15.5% downside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449630\" data-linked=\"Liberty Global -2.9% as BofAML cuts to Underperform\" data-tweet=\"$LBTYA $LBTYB $LBTYK - Liberty Global -2.9% as BofAML cuts to Underperform https://seekingalpha.com/news/3449630-liberty-globalminus-2_9-bofaml-cuts-to-underperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3449630-liberty-globalminus-2_9-bofaml-cuts-to-underperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449627\" data-ts=\"1554902502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTLK\" target=\"_blank\">OTLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449627-outlook-therapeutics-down-42-on-pricing-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Outlook Therapeutics down 42% on pricing equity offering</a></h4><ul> <li>Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <a href=\"https://seekingalpha.com/pr/17472417-outlook-therapeutics-announces-pricing-public-offering-common-stock-warrants\" target=\"_blank\">prices</a> its public offering of 10,340,000 common shares and a 15-month and a 5-year warrant to same number of common shares, respectively. BioLexis Pte. Ltd., led this financing with a $10M investment.</li>   <li>The shares of common stock and accompanying warrants are sold at a combined price of $2.75.</li><li>The warrants will be exercisable immediately at $2.90 per share. The expected gross proceeds are ~$28.4M.</li>  <li>Net proceeds will be used to fund clinical trials, for general corporate purposes, working capital needs, and scheduled repayments of $5M senior notes.</li><li>Closing date is April 12.</li><li>Shares are down <font color=\"red\">42%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3449627\" data-linked=\"Outlook Therapeutics down 42% on pricing equity offering\" data-tweet=\"$OTLK - Outlook Therapeutics down 42% on pricing equity offering https://seekingalpha.com/news/3449627-outlook-therapeutics-down-42-on-pricing-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3449627-outlook-therapeutics-down-42-on-pricing-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449623\" data-ts=\"1554902074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449623-cowen-raises-amd-on-better-positioning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen raises AMD on better positioning</a></h4><ul><li>Cowen raises its AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) price target from $28 to $33 citing increased confidence in its competitive position against Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>).</li><li>The firm believes near-term product launches will inflect in H2, showing early signs of long-term EPS and revenue power.</li><li>Cowen thinks AMD can take a more material portion of 7nm x86 PC and CPU TAM.</li><li>Rating maintained at Outperform.</li><li>AMD is expected to report earnings on April 24. Analysts <a href=\"https://seekingalpha.com/symbol/AMD/earnings\" target=\"_blank\">estimate</a> $1.26B in revenue with $0.06 EPS.</li><li>AMD shares are <font color=\"green\">up 0.9%</font> pre-market to $27.49.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449623\" data-linked=\"Cowen raises AMD on better positioning\" data-tweet=\"$AMD $AMD $INTC - Cowen raises AMD on better positioning https://seekingalpha.com/news/3449623-cowen-raises-amd-on-better-positioning?source=tweet\" data-url=\"https://seekingalpha.com/news/3449623-cowen-raises-amd-on-better-positioning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>94&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449622\" data-ts=\"1554901923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449622-srne-izea-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SRNE, IZEA among premarket gainers</a></h4><ul><li>ATA (NASDAQ:<a href='https://seekingalpha.com/symbol/ATAI' title='ATA Inc.'>ATAI</a>) <font color=\"green\">+27%</font>.</li><li>Global Brass and Copper Holdings (NYSE:<a href='https://seekingalpha.com/symbol/BRSS' title='Global Brass and Copper Holdings, Inc.'>BRSS</a>) <font color=\"green\">+26%</font> on being <a href=\"https://seekingalpha.com/news/3449617-global-brass-copper-bought-wieland-werke-44-share\" target=\"_blank\">acquired</a> by privately held Wieland-Werke AG for $44/share in cash.</li><li>Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"green\">+15%</font> on <a href=\"https://seekingalpha.com/news/3449526-safe-t-acquire-netnut-ltd-9_7m\" target=\"_blank\">acquiring</a> NetNut for $9.7M.</li><li>IZEA Worldwide (NASDAQ:<a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a>) <font color=\"green\">+12%</font> after double-digit bookings <a href=\"https://seekingalpha.com/news/3449494-izea-plus-17_6-percent-double-digit-bookings-growth\" target=\"_blank\">growth</a>.</li><li>Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <font color=\"green\">+11%</font> on <a href=\"https://seekingalpha.com/pr/17472402-sorrento-therapeutics-announces-discovery-potential-non-dopaminergic-approach-controlling\" target=\"_blank\">announcing</a> discovery of a potential non-dopaminergic approach to controlling Parkinson\u2019s Motor symptoms with resiniferatoxin intrathecal administration.</li><li>Boxlight (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight Corporation'>BOXL</a>) <font color=\"green\">+9%</font>.</li><li>Levi Strauss &amp; Co. (NYSE:<a href='https://seekingalpha.com/symbol/LEVI' title='Levi Strauss & Co.'>LEVI</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/news/3449441-levi-strauss-reports-q1-results\" target=\"_blank\">Q1 results</a>.</li><li>Guardant Health (NASDAQ:<a href='https://seekingalpha.com/symbol/GH' title='Guardant Health, Inc.'>GH</a>) <font color=\"green\">+5%</font> as liquid biopsy test to be covered in health care <a href=\"https://seekingalpha.com/news/3449543-guardant-healths-liquid-biopsy-test-covered-health-care-plans\" target=\"_blank\">plans</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449622\" data-linked=\"SRNE, IZEA among premarket gainers\" data-tweet=\"$AACG $BRSS $SFET - SRNE, IZEA among premarket gainers https://seekingalpha.com/news/3449622-srne-izea-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449622-srne-izea-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449620\" data-ts=\"1554901852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449620-pte-and-sbgl-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PTE and SBGL among premarket losers</a></h4><ul><li>Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"red\">-34%</font> on <a href=\"https://seekingalpha.com/pr/17472417-outlook-therapeutics-announces-pricing-public-offering-common-stock-warrants\" target=\"_blank\">pricing</a> equity offering.</li><li>PolarityTE (NASDAQ:<a href='https://seekingalpha.com/symbol/PTE' title='PolarityTE, Inc.'>PTE</a>) <font color=\"red\">-12%</font> on <a href=\"https://seekingalpha.com/news/3449439-polarityte-10-percent-hours-equity-offering\" target=\"_blank\">announcing</a> equity offering.</li><li>Niu Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NIU' title='Niu Technologies'>NIU</a>) <font color=\"red\">-8%</font>.</li><li>Homology Medicines (NASDAQ:<a href='https://seekingalpha.com/symbol/FIXX' title='Homology Medicines, Inc.'>FIXX</a>) <font color=\"red\">-7%</font> on <a href=\"https://seekingalpha.com/news/3449510-homology-medicines-prices-stock-offering-22_50\" target=\"_blank\">pricing</a> stock offering.</li><li>Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"red\">-7%</font> after <a href=\"https://seekingalpha.com/news/3449557-sibanye-stillwater-minus-8-percent-raising-120m-share-sale\" target=\"_blank\">raising</a> $120M from share sale.</li><li>PhaseBio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a>) <font color=\"red\">-6%</font> after <a href=\"https://seekingalpha.com/news/3449453-phasebio-files-equity-offering-shares-6-percent-hours\" target=\"_blank\">filing</a> for equity offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449620\" data-linked=\"PTE and SBGL among premarket losers\" data-tweet=\"$OTLK $PTE $NIU - PTE and SBGL among premarket losers https://seekingalpha.com/news/3449620-pte-and-sbgl-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3449620-pte-and-sbgl-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449617\" data-ts=\"1554901487\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRSS\" target=\"_blank\">BRSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449617-global-brass-and-copper-bought-wieland-werke-for-44-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Brass and Copper bought by Wieland-Werke for $44/share</a></h4><ul><li>Global Brass and Copper (NYSE:<a href='https://seekingalpha.com/symbol/BRSS' title='Global Brass and Copper Holdings, Inc.'>BRSS</a>) <font color=\"green\">+26.3%</font> pre-market after <a href=\"https://seekingalpha.com/pr/17472250-wieland-group-global-brass-copper-announce-definitive-merger-agreement\" target=\"_blank\">agreeing to be acquired</a> by privately held Wieland-Werke AG for $44/share in cash, representing a 27% premium to yesterday's closing price.</li><li>BRSS says the deal \"brings together two highly complementary companies with  diverse product offerings across copper and copper alloy strip and  sheet, rod, foil, wire, tube and fabricated components.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3449617\" data-linked=\"Global Brass and Copper bought by Wieland-Werke for $44/share\" data-tweet=\"$BRSS - Global Brass and Copper bought by Wieland-Werke for $44/share https://seekingalpha.com/news/3449617-global-brass-and-copper-bought-wieland-werke-for-44-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3449617-global-brass-and-copper-bought-wieland-werke-for-44-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449616\" data-ts=\"1554901466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449616-airline-stocks-higher-on-mix-of-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Airline stocks higher on mix of news</a></h4><ul>        <li>There's a lot of information for airline investors to chew on today.</li><li>First off is the latest government read on pricing. Air fares fell 0.6% M/M in March, according to data compiled by the Bureau of Transportation Statistics. Fares have now been lower in four of the last five months. Fares were down 2.9% Y/Y in March on an unadjusted basis (<a href=\"http://www.bls.gov/news.release/cpi.t02.htm\" target=\"_blank\">BTS data</a>).</li>     <li>Delta's earnings arrived also arrived in ahead of expectations this morning, with profit up 31% Y/Y and revenue at a record for the quarter. The company also guided Q2 EPS comfortably higher. Meanwhile, JetBlue's capacity in March rose <a href=\"https://seekingalpha.com/news/3449530-jetblue-airways-traffic-rose-7_9-percent-march\" target=\"_blank\">13%</a> Y/Y and the long-awaited jump across the Atlantic appears imminent.</li>  <li>Premarket action: Delta (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) <font color=\"green\">+2.55%</font>, JetBlue (NASDAQ:<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a>) <font color=\"green\">+3.88%</font>, American Airlines (NASDAQ:<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group Inc.'>AAL</a>) <font color=\"green\">+1.17%</font>, United Continental (NASDAQ:<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc.'>UAL</a>) <font color=\"green\">+1.13%</font>, Spirit Airlines (NYSE:<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines, Inc.'>SAVE</a>) <font color=\"green\">+0.85%</font>, Southwest Airlines (NYSE:<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a>) <font color=\"green\">+0.76%</font>, Hawaiian Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a>) <font color=\"green\">+0.65%</font>.</li> <li>Related ETF: <a href='https://seekingalpha.com/symbol/JETS' title='U.S. Global Jets ETF'>JETS</a>.</li>         </ul><div class=\"tiny-share-widget\" data-id=\"3449616\" data-linked=\"Airline stocks higher on mix of news\" data-tweet=\"$DAL $JBLU $AAL - Airline stocks higher on mix of news https://seekingalpha.com/news/3449616-airline-stocks-higher-on-mix-of-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3449616-airline-stocks-higher-on-mix-of-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449614\" data-ts=\"1554901188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGR\" target=\"_blank\">AVGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449614-avingerplus-24-on-fda-clearance-for-pantheris-sv-device\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avinger +24% on FDA clearance for Pantheris SV device</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17472147-avinger-receives-fda-clearance-pantheris-sv-device\" target=\"_blank\">grants</a> 510(k) clearance to Avinger's (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGR' title='Avinger, Inc.'>AVGR</a>) Pantheris SV (Small Vessel) image-guided atherectomy system.</li>         <li>Pantheris SV is indicated for the diagnosis and treatment of Peripheral Artery Disease in small vessels (2 to 4 millimeters in diameter).</li>        <li>The Company intends to initiate a limited launch in several sites in U.S. when commercial product is available.</li><li>Shares are up <font color=\"green\">24%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449614\" data-linked=\"Avinger +24% on FDA clearance for Pantheris SV device\" data-tweet=\"$AVGR - Avinger +24% on FDA clearance for Pantheris SV device https://seekingalpha.com/news/3449614-avingerplus-24-on-fda-clearance-for-pantheris-sv-device?source=tweet\" data-url=\"https://seekingalpha.com/news/3449614-avingerplus-24-on-fda-clearance-for-pantheris-sv-device\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449613\" data-ts=\"1554901085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INMB\" target=\"_blank\">INMB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449613-inmune-bio-poised-to-add-to-xpro1595-stoked-rally-up-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">INmune Bio poised to add to XPro1595-stoked rally, up 6% premarket</a></h4><ul><li>Ultra-thinly traded micro cap INmune Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/INMB' title='INmune Bio Inc.'>INMB</a>) is up <font color=\"green\">6% </font>premarket on light volume. Shares have rallied <font color=\"green\">34% </font>since Monday when it <a href=\"https://seekingalpha.com/pr/17469203-inmune-bio-announces-poster-presentation-new-data-regarding-neurodegenerative-disease-drug\" target=\"_blank\">announced </a>a data presentation on XPro1595 at the European Conference on Neuroinflammation.</li><li>Preclinical tests showed that <a href=\"https://www.inmunebio.com/index.php/en/science/xpro1595/overview\" target=\"_blank\">XPro1595</a>, a tumor necrosis factor &#40;TNF&#41;-targeting protein biologic, may promote remyelination in animal models of multiple sclerosis &#40;MS&#41; by increasing the presence of immune cells that remove damaged myelin, a key trigger for remyelination. TNF plays a key in inflammation.</li><li>Myelin, a mixture of proteins and phospholipids, is a protective sheath around nerve fibers that is damaged in MS by the body's own immune cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449613\" data-linked=\"INmune Bio poised to add to XPro1595-stoked rally, up 6% premarket\" data-tweet=\"$INMB - INmune Bio poised to add to XPro1595-stoked rally, up 6% premarket https://seekingalpha.com/news/3449613-inmune-bio-poised-to-add-to-xpro1595-stoked-rally-up-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3449613-inmune-bio-poised-to-add-to-xpro1595-stoked-rally-up-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449609\" data-ts=\"1554900569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONCS\" target=\"_blank\">ONCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449609-oncosecplus-6-on-introducing-new-technology-for-deep-visceral-lesions-ilminus-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OncoSec +6% on introducing new technology for deep visceral lesions with IL-12</a></h4><ul><li>OncoSec Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a>) has <a href=\"https://seekingalpha.com/pr/17472078-oncosec-announces-new-technology-treat-deep-visceral-lesions-ilminus-12\" target=\"_blank\">developed</a> a new, propriety technology to potentially treat pancreatic, liver and other difficult to treat visceral lesions through the direct delivery of plasmid-based interleukin-12 (IL-12) with a new Visceral Lesions Applicator &#40;VLA&#41;.</li><li>The company's new technology was published in a white paper titled \"Parachuting Behind Enemy Lines: OncoSec's Attack on Visceral Tumors via Its New Visceral Lesion Applicator.\"</li><li>The Company plans to introduce the new VLA, deploying its new product candidate, SPARK, and improved generator, APOLLO, in early 2020.</li><li>Shares are up <font color=\"green\">6%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449609\" data-linked=\"OncoSec +6% on introducing new technology for deep visceral lesions with IL-12\" data-tweet=\"$ONCS - OncoSec +6% on introducing new technology for deep visceral lesions with IL-12 https://seekingalpha.com/news/3449609-oncosecplus-6-on-introducing-new-technology-for-deep-visceral-lesions-ilminus-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3449609-oncosecplus-6-on-introducing-new-technology-for-deep-visceral-lesions-ilminus-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449607\" data-ts=\"1554900411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPX\" target=\"_blank\">TPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449607-tempur-sealyplus-8-after-mattress-firm-ceo-steps-away\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tempur Sealy +8% after Mattress Firm CEO steps away</a></h4><ul> <li>Tempur Sealy International (NYSE:<a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International, Inc.'>TPX</a>) is <font color=\"green\">8.44% higher</font> in premarket action after Mattress Firm's CEO steps down in an unanticipated move.</li> <li>Both Piper Jaffray and Wedbush Securities have stated in early notes out this morning to clients that TPX could benefit if the new Mattress Firm boss looks to rekindle the strained relationship between the bedding players.</li><li>TPX has cruised right past its 52-week high in the premarket session.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3449607\" data-linked=\"Tempur Sealy +8% after Mattress Firm CEO steps away\" data-tweet=\"$TPX - Tempur Sealy +8% after Mattress Firm CEO steps away https://seekingalpha.com/news/3449607-tempur-sealyplus-8-after-mattress-firm-ceo-steps-away?source=tweet\" data-url=\"https://seekingalpha.com/news/3449607-tempur-sealyplus-8-after-mattress-firm-ceo-steps-away\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449604\" data-ts=\"1554900233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KOOL\" target=\"_blank\">KOOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449604-thermogenesiss-axp-ii-and-pxp-systems-available-in-thailand\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ThermoGenesis&#39;s AXP II and PXP systems available in Thailand</a></h4><ul> <li>ThermoGenesis Corp., a wholly owned subsidiary of Cesca Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KOOL' title='Cesca Therapeutics Inc.'>KOOL</a>) <a href=\"https://seekingalpha.com/pr/17472043-thermogenesis-axp-ii-pxp-systems-now-registered-available-thailand\" target=\"_blank\">reports</a> that its AXP II System for cord blood processing and PXP System for point-of-care harvesting of highly enriched mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs) from bone marrow, are now registered and available for sale in Thailand.</li><li>KOOL shares are up <font color=\"green\">8%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3449604\" data-linked=\"ThermoGenesis&#39;s AXP II and PXP systems available in Thailand\" data-tweet=\"$KOOL $THMO - ThermoGenesis&#39;s AXP II and PXP systems available in Thailand https://seekingalpha.com/news/3449604-thermogenesiss-axp-ii-and-pxp-systems-available-in-thailand?source=tweet\" data-url=\"https://seekingalpha.com/news/3449604-thermogenesiss-axp-ii-and-pxp-systems-available-in-thailand\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449597\" data-ts=\"1554899597\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STMP\" target=\"_blank\">STMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449597-stamps-complus-2_5-upgraded-on-risk-reward-improvement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stamps.com +2.5% upgraded on risk/reward improvement</a></h4><ul><li>Maxim upgrades Stamps.com (NASDAQ:<a href='https://seekingalpha.com/symbol/STMP' title='Stamps.com Inc.'>STMP</a>) from Hold to Buy with a $98 price target (25% upside) saying the recent pullback improved the risk/reward balance.</li><li>STMP shares have <font color=\"red\">dropped 52%</font> in the past quarter, and the firm thinks the valuation now more than compensates for a lower earnings run rate and likely slower growth over the next two years.</li><li>Maxim thinks any wins of new carriers isn't priced into the stock and could provide an upside surprise to long-term growth.</li><li>STMP shares are <font color=\"green\">up 2.5%</font> pre-market to $80.29.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3442853-stamps-com-cfo-call-leaves-maxim-concerned\" target=\"_blank\">Stamps.com CFO call leaves Maxim concerned</a> (March 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3449597\" data-linked=\"Stamps.com +2.5% upgraded on risk/reward improvement\" data-tweet=\"$STMP - Stamps.com +2.5% upgraded on risk/reward improvement https://seekingalpha.com/news/3449597-stamps-complus-2_5-upgraded-on-risk-reward-improvement?source=tweet\" data-url=\"https://seekingalpha.com/news/3449597-stamps-complus-2_5-upgraded-on-risk-reward-improvement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449596\" data-ts=\"1554899488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449596-under-armour-gains-off-of-citi-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour gains off of Citi upgrade</a></h4><ul> <li>Under Armour (<a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc.'>UA</a>, <a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>) is recovering from yesterday's bruising at the hands of a <a href=\"https://seekingalpha.com/news/3449389-armour-minus-4-percent-b-riley-warning\" target=\"_blank\">B. Riley warning</a> after Citi takes its rating up to Buy from Neutral.</li> <li>Citi's <a href=\"https://www.cnbc.com/2019/04/10/calls-of-the-day-apple-disney-more.html\" target=\"_blank\">breakdown</a>: \"UAA is growing up with a renewed focus on driving profitability and ROIC. After chasing 20%+ top line growth during the 2010-2016 period, UAA has taken action to adapt to the changing athletic landscape. With just a 3.4% EBIT margin in 2018, UAA has the opportunity to recapture 600bps+ in EBIT margin over the next several years. And near-term, we see upside to management\u2019s F19 gross margin guidance.\"</li> <li>Citi analyst Kate McShane and team set a price target of $29 on UAA.</li> <li>UAA <font color=\"green\">+2.08%</font> premarket to $21.15. UA <font color=\"green\">+2.08%</font> to $19.10.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449596\" data-linked=\"Under Armour gains off of Citi upgrade\" data-tweet=\"$UA $UAA - Under Armour gains off of Citi upgrade https://seekingalpha.com/news/3449596-under-armour-gains-off-of-citi-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3449596-under-armour-gains-off-of-citi-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449583\" data-ts=\"1554898624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449583-tevas-rituxan-biosimilar-okd-in-canada\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva&#39;s Rituxan biosimilar OK&#39;d in Canada</a></h4><ul><li>Health Canada has <a href=\"https://seekingalpha.com/pr/17472038-teva-canada-announces-approval-truxima-first-biosimilar-rituxan-canada-treatment-non-hodgkins\" target=\"_blank\">approved</a> Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) subsidiary Teva Canada Innovation's TRUXIMA (rituximab), a biosimilar to Roche's (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding AG'>OTCQX:RHHBY</a>) RITUXAN, for the treatment of adult patients with non-Hodgkin lymphoma, chronic lymphocytic leukemia and rheumatoid arthritis.</li><li>TRUXIMA was approved in South Korea in 2016, in Europe in 2017 and in the U.S. last year.</li><li>Shares are up <font color=\"green\">2%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449583\" data-linked=\"Teva&#39;s Rituxan biosimilar OK&#39;d in Canada\" data-tweet=\"$TEVA $RHHBY - Teva&#39;s Rituxan biosimilar OK&#39;d in Canada https://seekingalpha.com/news/3449583-tevas-rituxan-biosimilar-okd-in-canada?source=tweet\" data-url=\"https://seekingalpha.com/news/3449583-tevas-rituxan-biosimilar-okd-in-canada\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449579\" data-ts=\"1554897948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEAR\" target=\"_blank\">HEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449579-turtle-beachplus-2-on-new-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turtle Beach +2% on new buyback</a></h4><ul><li>Turtle Beach (NASDAQ:<a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a>) <a href=\"https://seekingalpha.com/pr/17472105-turtle-beach-announces-15-million-share-repurchase-program\" target=\"_blank\">announces </a>a $15M share repurchase program that's expected to expire on April 9, 2021.</li><li>Turtle Beach shares are <font color=\"green\">up 2.4%</font> pre-market to $12.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449579\" data-linked=\"Turtle Beach +2% on new buyback\" data-tweet=\"$HEAR - Turtle Beach +2% on new buyback https://seekingalpha.com/news/3449579-turtle-beachplus-2-on-new-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3449579-turtle-beachplus-2-on-new-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449578\" data-ts=\"1554897706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALXN\" target=\"_blank\">ALXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449578-ubs-likes-gilead-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS likes Gilead in premarket analyst action</a></h4><ul><li>Alexion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a>) resumed with Outperform rating and $161 (17% upside) price target at Raymond James.</li><li>Biogen (NASDAQ:<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a>) resumed with Market Perform rating at Raymond James.</li><li>Cerner (NASDAQ:<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a>) upgraded to Buy with a $76 (21% upside) price target at SunTrust after adding $1.2B to its stock repurchase program and board pact with Starboard Value. Shares up <font color=\"green\">1%</font> premarket.</li><li>Guardant Health (NASDAQ:<a href='https://seekingalpha.com/symbol/GH' title='Guardant Health, Inc.'>GH</a>) upgraded to Buy with an $84 (27% upside) price target at BofA/Merrill Lynch after eviCore coverage of Guardant360 lung cancer test. Shares up <font color=\"green\">5% </font>premarket.</li><li>Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) upgraded to Buy with a $77 (17% upside) price target at UBS citing the upside with Descovy in PrEP and filgotinib in arthritis. Analyst Carter Gould still expects a Q1 EPS miss, however. Shares up <font color=\"green\">1%</font> premarket.</li><li>AmerisourceBergen (NYSE:<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a>) downgraded to Underperform with a $76 (2% downside risk) price target at BofA/Merrill Lynch. Downgraded to Neutral at Evercore ISI.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449578\" data-linked=\"UBS likes Gilead in premarket analyst action\" data-tweet=\"$ALXN $BIIB $CERN - UBS likes Gilead in premarket analyst action https://seekingalpha.com/news/3449578-ubs-likes-gilead-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3449578-ubs-likes-gilead-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449577\" data-ts=\"1554897676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSLR\" target=\"_blank\">FSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449577-first-solarplus-4-after-goldman-adds-to-conviction-buy-list\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Solar +4% after Goldman adds to Conviction Buy List</a></h4><ul><li>First Solar (NASDAQ:<a href='https://seekingalpha.com/symbol/FSLR' title='First Solar, Inc.'>FSLR</a>) <font color=\"green\">+4.3%</font> pre-market after Goldman Sachs <a href=\"https://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Adds+First+Solar+%28FSLR%29+to+Conviction+Buy+List/15357103.html\" target=\"_blank\">adds the stock to its Conviction Buy List</a> and raises its price target to $75 from $64, matching a Street high.</li><li>Goldman's Brian Lee sees \"a backdrop of improving fundamentals in the  global solar landscape\" in addition to \"continued strength in the U.S.  utility-scale development pipeline, a tailwind FSLR is well positioned  to harvest.\"</li><li>Lee also cites FSLR\u2019s ability to expand its capacity in Malaysia,  which \"could add as much as 23% upside to our 2021E EPS, all else being  equal.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3449577\" data-linked=\"First Solar +4% after Goldman adds to Conviction Buy List\" data-tweet=\"$FSLR - First Solar +4% after Goldman adds to Conviction Buy List https://seekingalpha.com/news/3449577-first-solarplus-4-after-goldman-adds-to-conviction-buy-list?source=tweet\" data-url=\"https://seekingalpha.com/news/3449577-first-solarplus-4-after-goldman-adds-to-conviction-buy-list\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449573\" data-ts=\"1554897613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIDU\" target=\"_blank\">BIDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449573-baidu-downgraded-on-spending\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baidu downgraded on spending</a></h4><ul><li>Oppenheimer downgrades Baidu (NASDAQ:<a href='https://seekingalpha.com/symbol/BIDU' title='Baidu, Inc.'>BIDU</a>) from Outperform to Perform and removes its $205 PT citing higher spending that will keep BIDU shares range-bound through 2019.</li><li>The firm sees higher investments in \"key strategic areas\" like content, short video, and cloud computing but doesn't expect to see revenue benefits until late 2019 or early 2020.</li><li>In the meantime, Oppenheimer expects Baidu \"will see meaningful negative estimate revisions over the next earnings cycle.\"</li><li>Baidu shares are <font color=\"red\">down 0.9%</font> pre-market to $179.47.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449573\" data-linked=\"Baidu downgraded on spending\" data-tweet=\"$BIDU - Baidu downgraded on spending https://seekingalpha.com/news/3449573-baidu-downgraded-on-spending?source=tweet\" data-url=\"https://seekingalpha.com/news/3449573-baidu-downgraded-on-spending\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449572\" data-ts=\"1554897358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449572-baml-confident-on-bed-bath-beyond\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML confident on Bed Bath &amp; Beyond</a></h4><ul> <li>Bank of America Merrill Lynch lifts EPS estimates on Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) on its view that drivers for EPS growth exist.</li> <li>\"While it\u2019s very unlikely that BBBY will return to peak margins, after years of overspending and numerous cost inefficiencies, we see no reason that BBBY couldn\u2019t see hundreds of basis points of improvement,\" advises BAML.</li> <li>\"The biggest opportunities appear to be in advertising, tech spending, leases, coupon expense, product sourcing and compensation.\"</li> <li>Analyst Curtis Nagle and team raise the 2019 EPS estimate on Buy-rated BBBY to $1.96 from $1.71 and take the 2020 EPS estimate to $2.49 from $1.54. A price objective of $25 is set.</li> <li>Shares of Bed Bath &amp; Beyond are <font color=\"green\">up 2.11%</font> in premarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449572\" data-linked=\"BAML confident on Bed Bath &amp; Beyond\" data-tweet=\"$BBBY - BAML confident on Bed Bath &amp; Beyond https://seekingalpha.com/news/3449572-baml-confident-on-bed-bath-beyond?source=tweet\" data-url=\"https://seekingalpha.com/news/3449572-baml-confident-on-bed-bath-beyond\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449566\" data-ts=\"1554896690\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449566-nordstromplus-2-after-keybanc-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom +2% after KeyBanc upgrade</a></h4><ul> <li>KeyBanc takes Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom, Inc.'>JWN</a>) to an Overweight rating on a positive view of valuation.</li> <li>The firm points to Nordstrom's \"powerful\" brand strength and strong management team in particular.</li> <li>The price target on Nordstrom goes to $55 to rep 24% upside potential.</li> <li>Shares of Nordstrom are <font color=\"green\">up 1.65%</font> premarket to $44.90 vs. the 52-week trading range of $42.54 to $67.74.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449566\" data-linked=\"Nordstrom +2% after KeyBanc upgrade\" data-tweet=\"$JWN - Nordstrom +2% after KeyBanc upgrade https://seekingalpha.com/news/3449566-nordstromplus-2-after-keybanc-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3449566-nordstromplus-2-after-keybanc-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449565\" data-ts=\"1554896575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WVE\" target=\"_blank\">WVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449565-wave-extends-data-readouts-on-huntington-studies-to-year-end\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wave extends data readouts on Huntington studies to year-end</a></h4><ul><li>Citing slower-than-expected enrollment, Wave Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences Ltd.'>WVE</a>) has <a href=\"https://seekingalpha.com/pr/17471930-wave-life-sciences-provides-timing-update-precision-hd-clinical-programs\" target=\"_blank\">revised the expected readout</a> of topline data from two Phase 1b/2a clinical trials evaluating WVE-120101 and WVE-120102 in Huntington's disease patients to year-end.</li><li>The company says the delay is not due to any safety signals.</li><li>In January, it <a href=\"https://seekingalpha.com/news/3426175-wave-life-sciences-4-percent-disclosure-fda-action-huntingtons-programs\" target=\"_blank\">disclosed </a>that the FDA placed a partial clinical hold on the programs citing the need for an additional preclinical study before allowing escalation to the highest dose in the first stage of the trials.</li><li><strong>Update</strong>: Shares are down <font color=\"red\">4%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449565\" data-linked=\"Wave extends data readouts on Huntington studies to year-end\" data-tweet=\"$WVE - Wave extends data readouts on Huntington studies to year-end https://seekingalpha.com/news/3449565-wave-extends-data-readouts-on-huntington-studies-to-year-end?source=tweet\" data-url=\"https://seekingalpha.com/news/3449565-wave-extends-data-readouts-on-huntington-studies-to-year-end\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449561\" data-ts=\"1554895934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HSDT\" target=\"_blank\">HSDT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449561-fda-thumbs-down-on-clearance-of-helius-pons-device\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA thumbs down on clearance of Helius&#39; PoNS device</a></h4><ul><li>The FDA has <a href=\"https://seekingalpha.com/pr/17471977-helius-medical-technologies-inc-provides-update-fda-s-review-request-de-novo-classification\" target=\"_blank\">rejected </a>Helius Medical Technologies' (NASDAQ:<a href='https://seekingalpha.com/symbol/HSDT' title='Helius Medical Technologies, Inc.'>HSDT</a>) application for De Novo status and 510(k) clearance of its Portable Neuromodulation Stimulator (PoNS). The agency cited the lack of sufficient information to determine the relative contributions of the PoNS device and physical therapy in its clinical trials.</li><li>The FDA stated that the company may refile its application after generating additional data.</li><li>CEO Philippe Deschamps says, \u201cWe are understandably disappointed by the Agency\u2019s decision to decline our <a href=\"https://seekingalpha.com/news/3387456-helius-medical-submits-request-fda-510-k-clearance-pons-device\" target=\"_blank\">request</a> for [approval], but Helius remains committed to generating the data [to support approval] of our PoNS device in the future for the treatment of patients with chronic balance deficit due to mmTBI, in order to bring our innovative therapy to more than 1.5 million Americans suffering from this condition. In addition to working on generating this new data, we will continue to focus on expanding our commercial efforts and treating patients in Canada, where we do currently have regulatory clearance.\"</li><li>Shares, currently halted, will resume trading at 7:35 am ET.</li><li><strong>Update</strong>: Shares are down <font color=\"red\">57%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449561\" data-linked=\"FDA thumbs down on clearance of Helius&#39; PoNS device\" data-tweet=\"$HSDT - FDA thumbs down on clearance of Helius&#39; PoNS device https://seekingalpha.com/news/3449561-fda-thumbs-down-on-clearance-of-helius-pons-device?source=tweet\" data-url=\"https://seekingalpha.com/news/3449561-fda-thumbs-down-on-clearance-of-helius-pons-device\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449559\" data-ts=\"1554895681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRS\" target=\"_blank\">AMRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449559-amyris-down-5-on-receiving-nasdaq-deficiency-notice\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amyris down 5% on receiving Nasdaq deficiency notice</a></h4><ul> <li>Nasdaq has <a href=\"https://seekingalpha.com/pr/17471646-amyris-receives-notification-deficiency-nasdaq-related-delayed-annual-report-form-10-k\" target=\"_blank\">sent</a> a non-compliance notice to Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>), as a result of delay in filing Form 10-K for the year ended December 31, 2018.</li>   <li>Amyris has 60 calendar days from the date of the letter to submit a plan to regain compliance.</li><li>Shares are down <font color=\"red\">5%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3449559\" data-linked=\"Amyris down 5% on receiving Nasdaq deficiency notice\" data-tweet=\"$AMRS - Amyris down 5% on receiving Nasdaq deficiency notice https://seekingalpha.com/news/3449559-amyris-down-5-on-receiving-nasdaq-deficiency-notice?source=tweet\" data-url=\"https://seekingalpha.com/news/3449559-amyris-down-5-on-receiving-nasdaq-deficiency-notice\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449558\" data-ts=\"1554895543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449558-delta-air-linesplus-3-after-unit-revenue-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta Air Lines +3% after unit revenue beat</a></h4><ul> <li>Shares of Delta Air Lines (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) rise in early trading after the company tops estimates with its <a href=\"https://seekingalpha.com/pr/17471968-delta-air-lines-announces-2019-march-quarter-profit\" target=\"_blank\">Q4</a> report.</li> <li>The company says top line growth of 7.5% was driven by improvements across Delta's business, including an 8% increase in premium product ticket revenue and double-digit percentage increases in loyalty and maintenance/repair/overhaul revenue. Cargo revenue declined 5% during the quarter on lower volumes.</li><li>Unit revenue was up 2.4% during the quarter to top the guidance mark of 2% and cost per available seat mile fell 0.2% vs. the guidance range of 0.0% to +0.5%.</li> <li>Looking ahead, Delta expects Q2 revenue growth of 6% to 8% and EPS of $2.05 to $2.35 vs. $2.13 consensus. Unit revenue growth of 1.5% to 3.5% is anticipated.</li> <li>DAL <font color=\"green\">+2.65%</font> premarket to $58.42.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3449544-delta-air-lines-beats-0_05-beats-revenue\" target=\"_blank\">Delta Air Lines beats by $0.05, beats on revenue</a> (April 10)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3449558\" data-linked=\"Delta Air Lines +3% after unit revenue beat\" data-tweet=\"$DAL - Delta Air Lines +3% after unit revenue beat https://seekingalpha.com/news/3449558-delta-air-linesplus-3-after-unit-revenue-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3449558-delta-air-linesplus-3-after-unit-revenue-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3449557\" data-ts=\"1554895467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGL\" target=\"_blank\">SBGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3449557-sibanye-stillwaterminus-8-after-raising-120m-from-share-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sibanye-Stillwater -8% after raising $120M from share sale</a></h4><ul><li>Sibanye-Stillwater (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"red\">-7.9%</font> pre-market and tumbles as much as 15% in Johannesburg after <a href=\"https://af.reuters.com/article/investingNews/idAFKCN1RM0QA-OZABS\" target=\"_blank\">raising $120M</a> (1.7B rand) in a share placement that analysts say <a href=\"https://www.businesslive.co.za/bd/companies/mining/2019-04-10-sibanye-raises-r17bn-in-an-oversubscribed-share-placing/\" target=\"_blank\">suggests some desperation</a> regarding its balance sheet.</li><li>The placement, which was offered to existing and new institutional investors, was at a price of ZAR15.50/share, a discount of 2% to the average price over the past 30 days on a volume-weighted average basis.</li><li>SBGL had sought to raise ZAR1.8B to position itself for labor talks and to restructure its gold mines; the placement represents 5% of its issued shares.</li><li>SBGL is worried about its ability to manage its debt obligations in the near term, but the amount raised will not move the company significantly into the black, says Hurbey Geldenhuys, head of research at Vunani Securities, adding that further risks could lead to larger and cheaper rights  offerings later in the year.</li><li>The miner says <a href=\"http://www.miningweekly.com/article/sibanyes-first-quarter-gold-production-falls-on-strike-impact-2019-04-09\" target=\"_blank\">Q1 gold production was hurt</a> by the ongoing AMCU strike and is expected to total 104K oz., 90% of what was planned under strike  conditions and 36% of production levels relative to the year-ago quarter; unit  operating and all-in sustaining costs will be hurt by the reduced  production levels.</li></ul><div class=\"tiny-share-widget\" data-id=\"3449557\" data-linked=\"Sibanye-Stillwater -8% after raising $120M from share sale\" data-tweet=\"$SBGL - Sibanye-Stillwater -8% after raising $120M from share sale https://seekingalpha.com/news/3449557-sibanye-stillwaterminus-8-after-raising-120m-from-share-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3449557-sibanye-stillwaterminus-8-after-raising-120m-from-share-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}